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INTRODUCTION
In recent decades advances have been made in the develop-
ment of transplantation. In Europe more than 30 thousand
transplants of organs (kidneys, liver, heart, lungs, and pan-
creas) are made yearly. New immunosuppressants have
been brought into practice, which have allowed to achieve
90% implant survival for one year. The main unsolved
problem is still securing long-term survival of allografts, the
function of which progressively decreases within 5 to 10
years (Nankivel and Chapmen, 2006). It is still not possible
to significantly reduce the period and the degree of chronic
allograft injuries. Available radiological, clinical and bio-
chemical and pathohistological methods of diagnostics and
the available treatment used in practice are not sufficient to
evaluate all difficulties in selection of organs, prevention of
ischemia-reperfusion complications, understanding of trans-
plant pathophysiology, etc. (Danovitch, 2010). Clinical and
diagnostic problems such as acute and chronic rejections,
infections, nephrotoxicity of immunosuppressive drugs re-
main important issues. It is still not clear how to assess the
numerous processes taking place in allografts (immunologi-
cal, reperfusion, mutational, etc.). Studies of processes tak-
ing place in the patient and their allografts under conditions
of immunosuppressive therapy combining different drugs
are of particular importance (Stock and Kirk, 2011). These
drugs have side effects that can cause infections, nephrotox-
icity, hypertension, and diabetes. Therefore, it is rather dif-
ficult to standardise post-transplant treatment.
THE ROLE OF BIOMARKERS IN MEDICINE
New biomedical technologies, among which particular at-
tention is paid to the study of biological markers (biomark-
ers), can be used to solve transplantation problems. Bio-
markers are characteristics that can be objectively measured
in a human and evaluated as indicators of normal biologic
processes, pathogenic processes, expected future disease de-
velopment, and responses to pharmacological and therapeu-
tic interventions. These indicators are distributed within a
population, present in biological substances and are indica-
tors of specific physiological and pathological conditions of
the body (Anonymous, 2001). Biomarkers must be quantita-
tive diagnostic endpoints, specific for each body and must,
at the same time, demonstrate the extent of its injury. They
must be easily measurable, simple and cheap. The main role
of biomarkers in the clinic lies in the study of the course of
diseases, assessment of the risk of their development based
on noninvasive techniques, prognostication, as well as re-
vealing the efficacy of therapeutic measures (Vasan, 2006).
Three types of biomarkers have been distinguished:
Type 0. A marker of a specific disease which correlates
with known clinical indices. Biomarkers of tumours and
cardiovascular diseases are widely known and used in prac-
tical work (Foster and Cooper, 2006).
Type 1. A marker that captures and assesses the effects of a
therapeutic intervention in accordance with its mechanism
of therapeutic action.
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Type 2. Surrogate end point. The marker intended to substi-
tute a clinical end point. A surrogate end point is expected
to predict clinical benefit (or harm or lack of benefit) on the
basis of epidemiological, therapeutic, pathophysiological or
other scientific evidence (De Gruttola, 2001).
There are many problems in transplantation that must be
solved through studies of biomarkers: study of pheno- and
genotype of patients with the aim to determine fitness for
transplantation treatment; discovery of risk factors of the
development of acute and chronic rejection, early diagnos-
tics of rejection, determination of its type, prognostication
of treatment outcomes and tailoring of immunosuppressive
therapy in a cost-effective manner (Springers et al., 2011).
Donors and recipients of renal allografts are the best models
to study biomarkers in transplantation. This may be ex-
plained by a significantly higher number of renal transplan-
tations compared to other organs, and by the possibility to
conduct studies at the same time in blood, urine and renal
allograft focusing on cells infiltrating walls of its tubules
(Gillespie and Lee, 2008). Moreover, there have been ad-
vancements in use of biomarkers in the diagnostics and
prognostication of acute renal failure, and this information
can be extrapolated to studies of the structure and function
of renal allografts (McIlroy et al., 2010).
CLINICAL AND BIOCHEMICAL CRITERIA
Currently, clinical and biochemical criteria are the most
widespread methods of diagnostics in pre and post kidney
transplantation patients. The determination of blood serum
creatinine is a “gold standard” in the assessment of allograft
function. This criterion fully suits clinicians, since it reflects
the degree of preservation of glomerular filtration. How-
ever, changes in the creatinine level take place only when it
drops to 50% (Waikar et al., 2012). The blood creatinine
level is not sufficient to diagnose a complicated pathology
of a renal allograft, the nature of rejections, the effect of
immunisuppressive therapy, possible tolerance, etc.
Other endpoints used in nephrologic clinics are also impor-
tant. Proteinuria, for example, is a diagnostic and prognostic
criterion for the development of pathology of original kid-
neys and also renal allografts. However, the estimated level
of proteinuria not only estimates renal dysfunction, but also
characterizes the consequences of pathological processes
taking place in allografts (Calabuig et al., 2012). In the
post-transplant period, significant importance is paid to se-
rum albumin concentration. An association between serum
albumin concentration and kidney transplant outcome has
been established (Molnar et al., 2011). Clinical and bio-
chemical endpoints are also used in transplantation of other
organs: activity of serum transaminase in cases of trans-
plants of liver; and blood glucose and amylase concentra-
tions in cases of pancreas transplants (Hrick, 2011). In-
creased activity of lysosomal enzymes, glutathione
S-transferase and N-acetyl-beta-D-glucosaminidase in
perfusate during machine preservation of kidneys, indicates
the beginning of injury (Graetz et al., 2009). Although the
above mentioned clinical endpoints apparently have clinical
value, it should be noted that they are not specific and de-
pend on a large range of numerous side effects related to the
disease and transplantation.
Histopathological studies of allografts allow more accurate
diagnostics. The Banff Classification allows to determine
different forms of rejection (Henderson et al., 2011). The
presence of CD4 antibodies in peritubular capillaries of a
renal allograft indicate humoral nature of an acute rejection
(Loupy et al., 2011). These observed changes are however
not always specific and many pathological findings remain
unexplained. It is not clear how to interpret borderline
changes identified in biopsies, the meaning of cellular infil-
tration without tubulitis, etc. (Snanoudj et al., 2011).
In immunological monitoring under conditions of immuno-
suppressive therapy, the assessment of the whole complex
of clinical and morphological criteria as biomarkers showed
their shortcomings in the prognostication of the develop-
ment of pathological processes and in determination of pre-
transplantation risk factors. These criteria are able to diag-
nose only the final stage of development of pathophysio-
logical shifts.
MOLECULAR-LEVEL STUDIES
Further development of biomarkers was aided by molecu-
lar-level studies. Advancements in the diagnostics and prog-
nostication of the development of acute renal failure al-
lowed their use in renal transplantation clinics (Coca et al.,
2008). A significant number of biomarkers were proposed,
but only Cystatin C, NGAL (neutrophil gelatinase-associ-
ated lipocalin), IL-18 (interleukin), and KIM-1 (kidney in-
jury molecule) should be considered to be the most prospec-
tive. Cystatin C (low-molecular-weight protein cysteine) is
a marker of glomerular filtration and reflects its level much
more accurately than blood creatinine. For fast diagnostics
of acute renal injuries in renal allografts, NGAL is most fre-
quently used (Jushinskis et al., 2011). It is a low molecular
weight protein located in neutrophiles and the epithelium,
including proximal renal tubules in the epithelium. In cases
of ischemic kidney injury, urine NGAL concentrations in-
crease. Its dynamic changes in urine and blood are success-
ful for determination of the extent and rate of restoration of
function of renal allografts after surgery (Hollmen et al.,
2011). IL-18 protein, a mediator of tubular necrosis, induces
neutrophil and monocyte infiltration of tubules during
ischemia. A dynamic study of NGAL along with IL-18 is
efficient for the prognostication of the development of de-
layed function and control of its recovery (Parikh et al.,
2006). Neopterin and C-reactive protein are used as markers
of cell-mediated immunity when transplanting heart. Their
elevation in urine and blood respectively indicate develop-
ment of an acute rejection (Johnson et al., 2011).
Improved diagnostics and prognostication of acute injuries
to renal allografts based on molecular tests using en-
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zyme-linked immunosorbent assay methods (ELISA) have
been shown to have low efficiency in the solution of many
other transplantation problems: determination of mecha-
nisms and pathophysiology of immune response, early diag-
nostics of rejections, and prognostication of the risk of de-
velopment of complications after organ transplantation.
Biomarkers to carry out complex multi-factor diagnostics
are needed. Some of these methods have already been used
in clinics. To prognosticate the most dangerous antibody-
mediated rejection, the level of donor-specific antibodies
can be determined using Luminex single antigen beads, in
which up to 100 different proteins are fixed simulteneously
on the surface of microspheres. This method allows to de-
termine indications for desensitization in the pre- and
post-transplantation period (Akalin et al., 2008). It was also
used to investigate antibodies to rare antigens. In patients
with a high pre-transplantation level of donor-specific anti-
bodies, the antibodies to donor MHC class 1 chain-related
antigen A (MICA) and B (MICB) were used as biomarkers,
which improved the diagnostics of acute humoral rejections
(Zou et al., 2007). For possible prevention and diagnostics
of cellular rejection, the interferon- gamma ELISPOT assay
was shown to be efficient as a biomarker to determine
alloreactivity of T cells. The correlation between the level
of T-cells and acute rejection was demonstrated 6 and 12
months after renal transplantation (Nickel et al., 2004). The
immunoadsorption blood test method in patients may also
be used to individualize immunosuppressive therapy
(Bestard et al., 2011). In addition, kidney biopsies can re-
veal the extent of inflammatory changes (Einke et al.,
2010).
A significant number of biomarkers are assessed using
immunoenzymometric and immunoadsorption assays,
which are efficient, but have not clarified the main issue:
how to achieve personalisation when transplanting organs,
which is a complex multi-factor treatment method. Every
body has individual reaction to the graft; the response of the
body to immunosuppressive therapy, different regimens and
also to doses. Each individual differs not only in immuno-
genetics, but also pharmacogenetics. It is possible to im-
prove the outcomes of transplantation only by personali-
sation of treatment.
OMICS IN TRANSPLANT MEDICINE
The implementation of OMIC started ten years ago by using
high tech in transplantation. The name neologism OMICS
was coined by the use of these letters after a particular field
of scientific studies in biology and medicine (for example,
genomics, proteinomics, etc.). In organ transplantation, the
term transplantomics is used. These studies integrate multi-
ple gene, protein, and metabolite expression in blood, urine
and allografts. A wide range of conducted studies has pro-
vided encouraging results.
To study the gene expression, the use of profile microchips
(gene expression profiling, mRNA expression microarray,
micro RNA) has provided new data regarding prognostica-
tion and diagnostics of acute rejection episodes. The work
of M. Suthanthrian’s team demonstrated an increase in gene
expression in urine sediment in cases of suspected acute re-
jection (Anglicheau and Suthanhiran, 2008; Suthanthiran et
al., 2011). Genomics methods turned out be be prospective
also in the study of bioptates (Reeve et al., 2009). The effi-
ciency of diagnostics of acute and chronic rejection of renal
allografts and the opportunity to individualise immuno-
suppressive therapy have been demonstrated (Flechner et
al., 2004; Halloran, 2010). Investigations on prognostica-
tion and early diagnostics of the extent of chronic injuries to
allografts are of special interest. In long-term observation of
gene expression dynamics can indicate development of in-
terstitial fibrosis and tubular atrophy of renal allografts
(Muthukumar et al., 2011). Gene technology can be used to
reveal the extent of ischemia-reperfusion complications dur-
ing zero-hour and one-hour biopsy of renal allografts (Mba
et al., 2011), and after renal transplantation (Farid et al.,
2011). Important prospects have opened up by using
genomics to clarify the tolerance problem, when stable
allograft function must be secured at minimum or no
immunosuppression (Sagoo et al., 2011). Knowledge of
gene polymorphism and expression therefore makes it pos-
sible to select patients with low immunological risk and, re-
spectively, low immunosuppression, which is required for
transplantation (Brouard et al., 2007).
A large number of studies in transplantation are focused on
proteomics (Klienzl-Wagner et al., 2011). Mass spectrome-
try and flow cytometry methods can be used to determine
the activity of proteins and polypeptides in urine, blood and
allografts, which can indicate various pathological condi-
tions. Tubulitis in renal allografts can be revealed by raised
chemokine levels in the urine, an early symptom of acute
rejection (Ho et al., 2011). Moreover, increase in chemo-
kine CMP-1 levels in urine during six months after trans-
plantation is correlated with the development of interstitial
fibrosis and tubular atrophy and is the most important crite-
rion of chronic injury of renal allografts (Ho et al., 2010).
The correlation between changes taking place in 40 urine
peptides and transcriptional (gene) data from puncture biop-
sies, and thus peptide levels could be used to indicate devel-
opment of acute rejection in renal allografts. The study of
proteins in a cardiac allograft showed different arrangement
during acute episodes and at other times (Borozdenkova et
al., 2004). Simultaneous determination of levels and ar-
rangement of 19 proteins in urine was used to assess inter-
stitial fibrosis and tubular atrophy, an indication for chronic
allograft injury (Quintana et al., 2009). A dynamic study of
the protein profile in urine can be used to diagnose the de-
gree of ischemia-reperfusion complications (Mueller et al.,
2011), non-immune injury to renal allografts (Banon-
Maneus et al., 2010) and to carry out their differential diag-
nosis with BK virus nephropathy (Jahnukainen et al., 2006).
Due to constant lack of organs for transplantation and the
use of marginal donors, issues of preservation of organs re-
mains and important issue. Studies have reported on means
to prognosticate renal function by protein group concentra-
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tions in the perfusate (Matar et al., 2011). These studies
seem particularly important to us and also to all clinicians
involved in kidney transplantation.
The study of the distribution of expressed genes and pro-
teins before and after organ transplantation provides a
unique opportunity to determine changes related to trans-
plantation at a higher level than before. These studies com-
plement each other, and there is no correlation or direct as-
sociation between the RNA distribution in cells and tissues
and the number of functional proteins (Tiers and Mann,
2003).
When analyzing the state of transplantation using bio-
markers, it should be noted that their combined use appar-
ently is the only opportunity to further improve outcomes of
organ transplantation (Table 1). The first studies have al-
ready turned out to be prospective for the understanding of
mechanisms of immune response, acute and chronic injury
of allografts. However, there is currently no biomarker that
can be used as a standard in the diagnostics of transplanta-
tion situations. There is a whole range of marker identifica-
tion problems, from correct blood sampling and handling to
adequate assessment of results. Also, it would be difficult, if
not impossible, to identify only one biomarker that would
be required to diagnose physiology and pathology of allo-
grafts. However, a set of biomarkers may be efficient, to
create an integral criterion combining blood, urine and
allograft sample tests obtained at the same time, particularly
after computer processing are developed for diagnostics and
personification of treatment (Roukas, 2010; Waldman and
Terzic, 2011). Currently intensive research is being carried
out to meet the biomarker challenges.
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T a b l e 1
THE USE OF BIOMARKERS IN PRE- AND POST-TRANSPLANTATION PERIOD FOR KIDNEY TRANSPLANTATION
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BIOMARÍIERI UN TO IESPÇJAMAIS LIETOJUMS TRANSPLANTÂCIJÂ
Raksts veltîts literatûras apskatam par divâm aktuâlâm mûsdienu medicînas tçmâm: transplantoloìiju un biomaríieriem. Sasniegtas pirmâs
sekmes imûnfermentatîvo un imûnsorbcijas metoþu izpçtç daþâdu transplantoloìijas klînikâ sastopamo situâciju izvçrtçðanâ. Tomçr ðîs
metodes nespçj atrisinât sareþìîtâkas un neskaidras problçmas transplantoloìijâ, tâdas kâ tolerance, ârstçðanas personifikâcija utt. Ðajâ
sakarâ tiek piedâvâti pirmie rezultâti no perspektîviem pçtîjumiem, izmantojot OMIC metodes: genomika, proteinomika u.c., kurus apvieno
kopçjais jçdziens — transplantomics.
Received 22 March 2012
224 Proc. Latvian Acad. Sci., Section B, Vol. 66 (2012), No. 6.
INTROUCTION
Faster and better postoperative recovery is an important
goal of modern surgery. In the early postoperative period,
pain and stress are the most common problems (Wu et al.,
2003; Ledowski et al., 2005; Ahonen et al., 2007; Jokela et
al., 2007; Wiley W. Souba, 2007). Systemic response to in-
jury or infection involves cell signaling, cell migration, and
mediator release. Minor host insults instigate a local inflam-
matory response that is transient and in most cases benefi-
cial. Major host insults may propagate reactions that can be-
come amplified, resulting in systemic inflammation and
potentially detrimental responses (Souba et al., 2007;
Brunicardi, 2010). Stress response to surgery is a compen-
satory mechanism, but it has been argued that this response
is unnecessary in current surgery. If the stress response is
prolonged, it results in decreased disease resistance, in-
creased morbidity and longer hospitalisation (Kehlet, 1997;
Deborah et al., 2004; Brunicardi, 2010). The stress response
to surgery includes a wide range of hormonal and metabolic
changes, among which two main systemic effects — the
neuroendocrine and the haemato-immunological effects —
can be distinguished (Desborough, 2000).
THE NEUROENDOCRINE RESPONSE TO SURGERY
The central nervous system (CNS) plays a key role in or-
chestrating the inflammatory response. The CNS influences
multiple organs through both neurohormonal and endocrine
signals (Brunicardi, 2010). The neuroendocrine response to
surgery is characterised by two main pathways: the hypo-
thalamic–pituitary–adrenal axis (HPA) and the sympa-
thetic–adrenal–medullary (SAM) axis (Elenkov et al., 2000;
Segerstrom et al., 2004; Miller et al., 2007). In the HPA
axis, activation is initiated during stress at the paraventricu-
lar nucleus of the hypothalamus, which secretes releasing
hormones (RHs). The hypothalamic releasing hormones
control the pituitary gland. The hypothalamus also exerts
direct neural control over the posterior pituitary gland (Ly-
ons et al., 1997).
The anterior pituitary gland synthesises six main hormones:
corticotropin, somatotropin, prolactin, thyrotropin, folli-
tropin and lutropin. Corticotropin, somatotropin and prolac-
tin secretion are increased under stress. The concentrations
of the other anterior pituitary hormones are not changed
markedly during surgical stress. The major role in the stress
response to surgery is played by corticotropin. Corticotropin
promotes cortisol production in the adrenal cortex. Cortisol
secretion increases several minutes after surgery, and the
cortisol concentration reaches a maximum at approximately
4–6 hours after surgery, depending on the severity of the
surgical trauma (Desborough, et al., 1993; Nicolson et al.,
1998). A feedback mechanism operates so that the increased
concentrations of circulating cortisol inhibit the secretion of
corticotropin by the pituitary gland, but this mechanism ap-
pears to be ineffective after surgery, and concentrations of
both hormones remain high. Cortisol promotes protein
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breakdown and gluconeogenesis in the liver as well as in-
hibits the use of glucose by cells. These effects lead to an
increased blood glucose concentration (Desborough, 2000).
Somatotropin has an important role in growth regulation
and in the cell’s metabolic processes. This hormone stimu-
lates protein synthesis and glycogenolysis, promotes lipoly-
sis, inhibits protein breakdown and has an anti-insulin ef-
fect. The concentration of somatotropin increases after
surgery in proportion to the severity of the injury (Desbor-
ough et al., 1999). Somatotropin inhibits glucose uptake
and use by cells (Grainne, et al. 2005). Prolactin secretion
increases as a part of the stress response to surgery. Prolac-
tin stimulates milk secretion from the breast and has a slight
metabolic influence during the stress response (Desborough,
et al., 1999).
Another pituitary hormone is thyrotropin. The thyrotropin
concentration may be slightly decreased during the first two
hours after surgery and then return to the preoperative level.
The target organ of thyrotropin is the thyroid gland, which
produces the thyroid hormones thyroxine (T4) and tri-
iodothyronine (T3). These hormones are bound to their
binding proteins, albumin, thyroxine-binding pre-albumin
and thyroid-binding globulin. The free thyroid hormones in
the plasma are metabolically active (Edwards, 1997). Thy-
roid hormones stimulate the oxygen consumption of most of
the metabolically active tissues of the body. As a result, cell
metabolism and heat production increase. The concentra-
tions of the thyroid hormones may decrease slightly after
surgery and return to normal in several days. These changes
may appear because of the close relationship between thy-
roid hormones, catecholamines and cortisol. Exogenous
steroids suppress T3 and T4; thus, hypercortisolaemia after
surgery may also depress the thyroid hormone levels (Cro-
izer et al., 1997; Desborough, 1999).
Follitropin and lutropin are also secreted from the anterior
pituitary gland. In females, follitropin is responsible for the
development of the ovarian follicles, and lutropin promotes
the maturation of these follicles. In males, follitropin main-
tains the spermatic epithelium, and lutropin stimulates the
testis cells. The follitropin and lutropin plasma concentra-
tions show variable changes after surgical stress (Desbor-
ough et al., 1999, Tilbrook et al., 2002).
Vasopressin, or arginine vasopressin, is secreted from the
posterior pituitary. Vasopressin has effects on the kidneys
and increases water absorption in the collecting ducts of the
nephron. These effects support the preservation of adequate
body fluid volumes. Vasopressin also has an endocrine
function, acting with corticoliberin to stimulate the secre-
tion of pro-opiomelanocortin from the anterior pituitary
(Grainne et al., 2005). The vasopressin concentration in-
creases in response to surgical stress (Desborough et al.,
1999).
In the SAM axis, activation involves preganglionic sympa-
thetic nervous system neurons that descend from nuclei in
the brain. The release of the neurotransmitter acetylcholine
from these neurons in the adrenal medulla stimulates cells
to secrete adrenaline. The post-ganglionic sympathetic ner-
vous system fibres, however, predominantly secrete
noradrenaline. Therefore, activation of the SAM mainly
leads to the release of both adrenaline and noradrenaline
(Elenkov et al., 2000). The above-mentioned processes lead
to the well-recognised cardiovascular effects of tachycardia
and hypertension. In addition, the functions of the liver,
pancreas, kidney and immune system are directly modified
by efferent sympathetic stimulation (Elenkov et al., 2000;
Sanders and Kavelaars, 2007). Pancreatic secretion is also
altered in response to surgical stress: glucagon secretion is
activated and insulin secretion is diminished. The decreased
insulin concentration may be caused partially by the inhibi-
tion of pancreas ß-cell secretion. There is also a failure of
the typical cellular response to insulin, the so-called “insulin
resistance”.
The plasma glucagon concentration increases transiently af-
ter surgery (Desborough, 2000; Grainne et al., 2005). Glu-
cagon promotes hepatic glycogenolysis and gluconeogene-
sis and increases the glucose concentration in the blood.
Other stress hormones, such as cortisol and catecholamines,
also facilitate glucose production as a result of increased he-
patic glycogenolysis and gluconeogenesis. These factors
cause the glucose concentration in the plasma to increase as
a response to stress after surgery, and they are related to the
intensity of the surgical injury. For example, in cardiac sur-
gery, blood glucose concentrations increase up to 10–12
mmol/l and remain elevated for 24 h after surgery (Anony-
mous, 1998; Grainne et al., 2005). The overall metabolic ef-
fects of the hormonal changes are the following: increased
catabolism, which mobilises substrates to provide energy
sources, and a mechanism to retain salt and water, thus
maintaining fluid volume and cardiovascular homeostasis
(Desborough et al., 1999).
THE HAEMATO-IMMUNOLOGICAL RESPONSE TO
SURGERY
The immune system has developed to respond to and neu-
tralize pathogenic micro-organisms as well as coordinate
tissue repair. Systemic inflammation is characterised by ex-
aggerated immune responses to either a sterile or infectious
process. The cause of inflammatory activation needs to be
addressed to resolve the dysregulated immune state
(Brunicardi, 2010). Recent years show that surgery and an-
aesthesia exert an immunosuppressive effect (Ogawa et al.,
2000, Zura et al., 2009, Veenhof et al., 2012). Both innate
and adaptive immune functions are depressed (Brand et al.,
2003; Franke et al., 2006; Zura et al., 2009). It has been
shown that the immune response is altered with respect to
phagocyte compromise, lymphocyte transformation, cyto-
toxicity, antibody response and the chemotactic functions of
immune cells (Buunen et al., 2004; Bengmark, 2006; Go-
lubovska et al., 2008). The balance between pro-inflam-
matory and anti-inflammatory processes is important.
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Cytokines play a major role in the regulation of the immune
response to surgery. Cytokines are a group of small cell-
signalling proteins that are essential for both the innate and
the adaptive immune responses. Cytokines are produced
mostly from activated leucocytes, monocytes, fibroblasts
and endothelial cells as an early response to tissue injury.
However, virtually all nucleated cells are potent producers
of cytokines. Cytokines act on surface receptors on many
different target cells, and they change protein synthesis
within cells. Cytokines mediate a broad sequence of cellular
responses, including cell migration, DNA replication, and
immunocyte proliferation (Brunicardi, 2010). More than 50
cytokines are known. After surgery, the main cytokines re-
leased are interleukin-1 (IL-1), interleukin-6 (IL-6), and tu-
mour necrosis factor. IL-6 is the main cytokine responsible
for inducing the systemic changes known as the acute-phase
response.
The changes that occur after surgery and tissue damage are
known as the acute-phase response. These changes are the
following: fever, leucocytosis, production of acute-phase
proteins in the liver and changes in the serum concentra-
tions of transport proteins. The combination of leucocytosis
with neutrophilosis is one of the immunological effects of
inflammation. Neutrophils are normally found in the blood
stream. Neutrophilosis occurs during the acute phase of in-
flammation, particularly as a result of bacterial infection,
environmental exposure, or surgical trauma. Neutrophils are
one of the first-responders among the inflammatory cells to
migrate towards the site of inflammation (Nathan, 2006).
They migrate through the blood vessels and interstitial tis-
sue, following chemical signals such as interleukin-8 (IL-8)
and leukotriene B4. Neutrophils are recruited to the site of
injury within minutes following trauma and are the hall-
mark of acute inflammation (Witko-Sarsat et al., 2000; Na-
than, 2006).
Another important part of the acute-phase response to surgi-
cal trauma is the production of acute-phase proteins in the
liver, such as C-reactive protein (CRP), fibrinogen,
2-macroglobulin and others. These proteins act as inflam-
matory mediators (Sheeran et al., 1997). The physiological
role of CRP is to bind to phosphocholine expressed on the
surface of dead or dying cells to activate the classical path-
way of the complement system via the C1Q (a sub-
component of C1 complement) complex. CRP enhances
phagocytosis by macrophages. Thus, CRP participates in
the clearance of necrotic and apoptotic cells. CRP also plays
an important role in immunity as a defence system against
infections (Pepys et al., 2003). In the acute- phase response,
the levels of CRP increase rapidly within two hours of sur-
gical trauma, reaching their peak during a period of 2–4
days afterwards. Upon the resolution of the acute-phase re-
sponse, CRP declines with a relatively short half-life of 18
hours. Measuring the CRP level is a screen of postoperative
inflammation. Rapid, marked increases in CRP occur with
inflammation, infection, trauma and tissue necrosis. The
half-life of CRP is constant, and therefore, its level is
mainly determined by the rate of production and the sever-
ity of trauma. Researchers have shown that the CRP con-
centration in the plasma is the main predictive factor of
worse physical condition after surgery (Hall et al., 2002).
BIDIRECTIONAL NEURO-IMMUNE COMMUNICA-
TION
The haemato-immune and neuroendocrine systems interact
closely, and one system influences the other during the
stress response in a bidirectional regulatory circuit (Fig. 1).
This regulation has been shown to be mediated in part
through hormones and cytokines. Both systems have recep-
tors for both types of signalling molecules (Elenkov et al.,
2000; Segerstrom et al., 2004; Miller et al., 2007). The two
main neuroendocrine pathways are the HPA and the SAM
axis. Many hormones from these endocrine pathways have
also been shown to be produced by, and have activity on,
lymphocytes. Examples include corticoliberin, somatotro-
pin, prolactin, thyrotropin, vasopressin and others (Smith,
2008). The catecholamines (adrenaline and noradrenaline)
can also influence immune cells, as all leukocytes express
adrenergic surface receptors (Smith, 2008).
Glucocorticoids have immunosuppressive properties. Im-
munologic changes associated with glucocorticoids include
thymic involution, depressed cell-mediated immune re-
sponses reflected by decreases in T-killer and natural killer
cell function, T-lymphocyte blastogenesis, mixed lympho-
cyte responsiveness, graft-versus-host reactions, and de-
layed hypersensitivity responses. Glucocorticoids inhibit
neutrophil superoxide reactivity, suppress chemotaxis, and
normalise apoptosis signalling mechanisms, but maintain
neutrophil phagocytic function. (Brunicardi, 2010). In addi-
tion, post-ganglionic nerve fibres directly innervate lym-
phoid organs, including the thymus, spleen, lymph nodes
and bone marrow, and influence the production and func-
tions of immune cells (Elenkov et al., 2000; Krüger et al.,
2007).
WAYS TO DECREASE THE STRESS RESPONSE TO
SURGERY
Among the many factors that can influence the stress re-
sponse to surgery, we can distinguish three main groups:
preoperative factors, perioperative factors, and postopera-
tive factors.
The preoperative factors
Psychological stress, anxiety and emotions. Fear, anxiety,
and psychological threat of danger in the preoperative pe-
riod can significantly reduce tolerance to pain and stress
(Tewes, 1999). It is known that the initiation of the stress
response is governed by a person’s ability to cope with a
particular stimulus. Therefore, psychological stress occurs
when a person’s ability to “cope” with a situation is ex-
ceeded (Wetsch, 2009). The stimuli pass to the limbic sys-
tem in the region of the amygdala and hippocampus and to
the posterior hypothalamus. Stimulation of the latter influ-
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ences pituitary functions and provokes stress-related
changes in an organism.
Ways to decrease the stress. To decrease anxiety in preoper-
ative periods, we can use adequate patient management and
preoperative teamwork. An important factor in decreasing
preoperative stress is the preoperative educational conversa-
tion. Patients are given information about the operation, an-
algesia, postoperative course, prognosis, etc. (Kitching et
al., 2009). Consideration should be directed to appropriate
premedication therapy: anxiolytics, such as benzodia-
zepines, are the most popular medication for reducing fear
and anxiety; additionally, painkillers such as COX-2 inhibi-
tors can be used as a preemptive analgesia before surgery to
reduce the pain and opioid requirements during the opera-
tion (Puura et al., 2006). COX-1 inhibitors are less advis-
able for preemptive analgesia because of antithrombotic ef-
fect and irritation of gastric mucosa, which can cause
ulceration and bleeding in postoperative period. There is
also an increasing interest in using -blockers; these drugs
can suppress the surgical induction of catecholamines and
2-agonists (e.g., clonidine), which can have an opioid-
sparing effect and reduce myocardial ischaemia (Kitching et
al., 2009).
Preoperative fasting and fluid balance. Traditionally, pa-
tients for elective surgery are fasted overnight to reduce the
aspiration risk; however, this practise can lead to dehydra-
tion. The reduction in the effective circulating volume is
sensed by the pressure-sensitive baroreceptors in the aorta,
carotid and renal arteries. Proportional to the magnitude of
the volume loss, the pituitary gland is activated, and stress
hormones are released (Manorama, 2003). Starvation also
stimulates catabolic processes and perioperative stress.
Ways to decrease the stress. Recent guidelines have recom-
mended a shift in fasting policy from the standard “nothing
by mouth after midnight” approach to more relaxed policies
that permit a period of restricted fluid intake up to two
hours before surgery (Scarlett et al., 2002). Permission for
clear fluid intake up to two hours preoperatively does not
result in a clinically important difference in the risk of re-
gurgitation and aspiration and can reduce perioperative
stress (Grocott, 2005; Stuart, 2006). The appropriate preop-
erative fluid therapy with a sufficient amount of glucose is
essential for maintaining the fluid balance and calorie re-
quirement to avoid undue catabolism and decrease postop-
erative nausea, vomiting and pain (Maharaj, et al., 2005;














Fig. 1. Bidirectional neuro-immune communi-
cation. HPA, hypothalamic–pituitary–adrenal
axis; SAM, sympathetic–adrenal–medullary
axis; RH, releasing hormones.
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The perioperative factors
Anaesthesia. The specialty of anesthesia is no longer limited
to the operating room. It is natural that anesthesiology, born
out of the quest to relieve pain, gave rise to the field of
acute and chronic pain medicine. The anesthesiologist con-
sulting on the acute pain service may recommend oral, IM,
or IV analgesia with a variety of agents, or patient-con-
trolled analgesia (Brunicardi, 2010). Anaesthetic manage-
ment depends on patient age, sex, concomitant diseases,
previous medical therapy, etc. and should be tailored to
each patient. General anaesthesia limits the perception of
sensations during surgery but has little effect on the stress
response to surgery, except for high-dose opioid anaesthe-
sia, which may inhibit intra- but not postoperative catabolic
hormonal changes (Golubovska et al., 2008). It has been
suggested that even deep general anaesthesia cannot com-
pletely block the hypothalamic reaction to the noxious stim-
uli from an operation field.
There are differences between the two main types of general
anaesthetic: inhalational and intravenous. Inhalational an-
aesthetics (e.g., isoflurane) have been associated with
greater inflammatory response and suppression of lympho-
cyte functions, which can lead to greater immune suppres-
sion morbidity in the postoperative period (Karabiyik et al.,
2001; Matsuoka et al., 2001). Intravenous anaesthetics have
different effects on stress: ketamine may play a role in re-
ducing postoperative pain and stress when used in addition
to opioids and local anaesthetics (Tverskoy at al., 1996;
Menigaux et al., 2000); in contrast, propofol promotes the
inflammatory response, deepens immune suppression and
supports bacterial proliferation (Bowdle et al., 2002;
Golubovska et al., 2008); benzodiazepines (e.g., mida-
zolam) suppress cortisol responses to abdominal surgery;
and opioids in high doses suppress the stress response and
promote surgery-induced immune suppression. However, in
upper abdominal surgery, opioids are ineffective in prevent-
ing the stress response to surgery (Desborough, 2000).
Ways to decrease the stress. The use of anaesthetics with
greater influence on surgical stress and a combination of in-
travenous and inhaled drugs is a reasonable option to de-
crease stress, although many intravenous and inhaled anaes-
thetics in normal doses have minor effects on the endocrine
and metabolic functions (Lin et al., 1999; Velikovic et al.,
2002; Manorama, 2003). Appropriate anaesthetic dosage is
an important option for decreasing the stress response to
surgery. Inadequate drug titration during anaesthesia may
result in light or deep anaesthesia. During light planes of an-
aesthesia, feelings of pain, inadequate sleep, amnesia or
muscle relaxation result in stress response. The careful titra-
tion of inhaled anaesthetic drugs and intravenous anaesthet-
ics and the use of cardio-stable muscle relaxants are helpful
to maintain adequate depth. The continuous infusion of an-
aesthetic drugs has proven to be excellent for preventing
fluctuations in the depth of anaesthesia (Manorama, 2003).
Another way to decrease the stress response to surgery is to
use local anaesthetics. The common characteristic of local
anaesthetics is a reversible block of the transmission of neu-
ral impulses when placed near a nerve membrane. The
neural block decreases the activation of HPA and SAM and
decreases neurogenic inflammation (Coderre et al., 1993;
Golubovska et al., 2008). Local anaesthetics have direct ef-
fects on endocrinal and metabolic responses. For example,
extensive epidural anaesthesia with local anaesthetics can
prevent the endocrine and metabolic responses to surgery in
the pelvis and on the lower limbs (Desborough, 2000;
Kawasaki et al., 2007). It is also assumed that local anaes-
thetics should decrease postoperative pulmonary complica-
tions and thromboembolic complications and improve pul-
monary functions (Pöpping et al., 2008). The use of local
anaesthesia improves gastrointestinal functions in the post-
operative period and can decrease paralytic ileus following
abdominal operations (Steinbrook, 1998). Local anaesthet-
ics may also have systemic anti-inflammatory effects and
decrease CRP and IL-6 (Hollmann et al., 2000, Bagry et al.,
2008). The usage of local anaesthetics during surgery can
be recommended to decrease stress-related changes.
If it is necessary to perform an operation under general an-
aesthesia, the combination of general anaesthetics with local
anaesthetics is one of the possible options. The preemptive
local anaesthesia is particularly effective when the neuronal
block is performed before nociceptive stimuli are triggered.
Recent studies show that this combination can decrease
neuroendocrine changes related to intraoperative stress and
can decrease postoperative pain (Manorama, 2003;
Barczynsk et al., 2006). For example, general anaesthesia
supplemented with epidural analgesia in hip replacement
and abdominal surgery certainly reduces the circulatory, hy-
perglycaemic responses due to the inhibition of cortisol and
the catecholamines (Velikovic et al., 2002).
Methods of surgical intervention. Surgery is an injury cre-
ated for the purpose of treatment. The inflammatory compo-
nent of the stress response depends on the extent of the
injury. Procedures of short duration or abdominal laparo-
scopic surgeries requiring small incisions and minimal tis-
sue handling evoke only a slight response. After laparo-
scopic operations, the increase in the concentrations of
biochemical markers of inflammation (IL-6, CRP etc.) is
not as great as after open surgery (Hollmann et al., 2000).
However, the classical stress responses (cortisol, glucose,
etc.) to abdominal surgery, such as cholecystectomy, are not
changed greatly by reducing surgical trauma (Velickovic et
al., 2002; Manorama, 2003). This observation suggests that
the stimuli for the stress response arise from visceral and
peritoneal afferent nerve fibres in addition to those from the
abdominal wall.
Ways to decrease stress. The use of minimally invasive sur-
gical techniques is generally associated with reduced pain
and shorter hospital stays compared with open techniques.
The appropriate usage of minimally invasive surgical tech-
niques is a considerable option to decrease the inflamma-
tory component of stress response and facilitate early dis-
charge.
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Perioperative fluid and temperature management. Haemo-
dynamic changes during endotracheal intubation, skin inci-
sion, and surgical manipulation provoke the secretion of
stress hormones and activate HPA and SAM. Additionally,
changes in the core temperature are sensed by the pre-optic
area of the hypothalamus, which induces the secretion of
stress hormones. Mild hypothermia (35–36°C) is associated
with adverse outcomes, including impaired drug metabo-
lism, prolonged recovery from anaesthesia, cardiac morbid-
ity, coagulopathy, wound infections, and postoperative
shivering (Insler et al., 2006). The administration of cold
fluids (i/v fluids, intraabdominal irrigation), large uncov-
ered skin incisions, and internal redistribution of body heat
cause body hypothermia.
Ways to decrease stress. It is essential to prevent any
haemodynamic changes during surgery. The administration
of i/v fluids to avoid dehydration, maintain an effective cir-
culating volume and prevent inadequate tissue perfusion
should be considered to be a core element of perioperative
management. A number of clinical studies support the no-
tion that an approach based on administering fluids to
achieve maximal left ventricular stroke volume (while
avoiding excess fluid administration and consequent impair-
ment of left ventricular performance) may improve out-
comes (Grocott et al., 2005). The maintenance of constant
core temperature also plays an important role in the
perioperative period. Core temperature can be influenced by
room temperature and body temperature. Control of body
temperature can be achieved by different methods, such as
perioperative warming of the patient, airflow blankets dur-
ing the operation, localised heat therapy, the administration
of warm fluids (i/v and intra-abdominally) and blood
warmers (Scherer, 1997).
Postoperative factors
Pain management. Surgical pain is caused by inflammation
from tissue trauma (surgical incision, dissection, or burns)
or direct nerve injury (nerve transaction, stretching, or com-
pression). Both factors activate HPA, SAM, and the stress
response.
Ways to decrease stress. Effective postoperative analgesia
is an essential factor for decreasing surgical stress. Absolute
pain relief is a “gold standard” for preventing the protein
breakdown and minimising endocrine and metabolic
changes to the stress response (Velickovic et al., 2002).
Pain relief can be achieved using different medications, in-
cluding opioids (e.g., morphine), non-steroidal anti-inflam-
matory drugs (NSAIDs), local anaesthetics (e.g., lidocaine)
and coanalgesic drugs (e.g., 2-agonists and anti-
convulsants). The major goal in the management of postop-
erative pain is minimising the dose of medications to dimin-
ish side effects while still providing adequate analgesia. To
achieve this goal, modern surgery uses a multimodal ap-
proach. The principle of the multimodal approach is to ob-
tain good analgesic effect from different sources. This prac-
tise maximises the analgesic effect and minimises side
effects, such as ileus, nausea, and sedation, especially those
of opioids (Kitching et al., 2009). There is evidence that
postoperative analgesia in combination with local anaesthet-
ics is associated with a faster resolution of postoperative
ileus and stimulates bowel motility. Additionally, the best
option is to use different combinations of local anaesthetics,
non-steroidal anti-inflammatory drugs, coanalgesics and
opioids. When using such an approach, the need for opioids
should be reduced (Rigg et al., 2002; Kitching et al., 2009).
Postoperative environment and nutrition. The other impor-
tant factor is the environment in which a patient is situated
after the operation. Behavioural and subjective changes are
a part of the response to surgery. Feelings of malaise and
postoperative fatigue have a strong influence on recovery
from surgery and return to work (Salmon et al., 1997).
Ways to decrease stress. Postoperative fatigue and feeling
of malaise is a complex multifactorial issue and can be de-
creased in a number of ways including early mobilisation,
the avoidance of sleep disturbance, and early enteral nutri-
tion. Such an “intensive” approach can be rewarded by
early discharge from the hospital (Kehlet, 1999). The goal
of nutritional support in the surgical patient is to prevent or
reverse the catabolic effects of disease or injury. Factors
that influence the choice of enteral formula include the ex-
tent of organ dysfunction (e.g., renal, pulmonary, hepatic, or
gastrointestinal), type of operation (e.g. gastrointestinal, or-
thopaedic etc.), the nutrients needed to restore optimal func-
tion and healing (Brunicardi, 2010). Early enteral nutrition
is an essential factor in postoperative recovery. Fears of
postoperative ileus and the integrity of the newly con-
structed anastomosis have led to treatment typically entail-
ing starvation with administration of intravenous fluids until
the passage of flatus. However, it has since been shown that
prompt postoperative enteral feeding in patients undergoing
gastrointestinal resection is both effective and well tolerated
even when started within 12 hours of surgery. Enteral feed-
ing is also associated with specific clinical benefits such as
reduced incidence of postoperative infectious complications
and an improved wound healing response (Kitching et al.,
2009). Postoperative nausea, vomiting and paralytic ileus
should be avoided, and enteral or oral feeding should be
used.
Bowel stimulation and enteral nutrition with a probiotics-
enhanced formula could be used. The term probiotic refers
to “live microorganisms which when administered in ade-
quate amounts confer a health benefit on the host”
(Gorbach, 2000). The microorganisms most frequently used
as probiotic agents are lactic acid bacteria (species of
Lactobacillus, Enterococcus, and Bifidobacterium) and
nonpathogenic antibiotic-resistant, ascosporic yeasts, espe-
cially Saccharomyces boulardii (Alvarez-Olmos et al.,
2001). Probiotics have well-known effects on bowel motil-
ity, postoperative ileus, immune system and bowel
microbiota (Freitas et al., 2003; Kraehenbuhl et al., 2004).
The postoperative use of probiotics is another possible op-
tion to decrease the effects of stress response to surgery and
decrease complications after surgery (Ivanovs et al., 2006).
Probiotics stimulate the proliferation of enterocytes
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(Ishikawa et al., 1999), change the immune activity in
gut-associated lymphoid tissue and decrease the prolifera-
tion of pathogenic flora in the bowel (Niers et al., 2004).
Recent studies show stimulating effects of probiotics on im-
munoglobulin secretion (Macpherson et al., 2004). Pro-
biotics have positive effects on leucocyte proliferation and
cytokine secretion. This is especially important in postoper-
ative stress, when both innate and adaptive immune func-
tions are depressed and when the balance between
proinflammatory and anti-inflammatory processes is im-
paired (Hart et al., 2004). Many studies have shown that
different species of probiotic bacteria have different actions;
therefore, it is better to use probiotics that contain multiple
bacterial species and different probiotic bacteria to achieve
the best result from probiotic therapy (Timmerman et al.,
2004; Marc et al., 2005).
CONCLUSION
The stress response to surgery comprises a number of
changes initiated by the neuronal activation of the hypotha-
lamic–pituitary–adrenal axis and sympathetic–adrenal–
medullary axis. The two main systemic changes are in the
neuroendocrine and haemato-immune systems. Both of
these systems have close interactions and influence one an-
other. We can distinguish three main possible ways to de-
crease the stress response to surgery:
1. In the preoperative period, the use of adequate preopera-
tive assessment; appropriate teamwork with a patient; edu-
cational conversation; and minimising preoperative starva-
tion and fluid restrictions.
2. In the perioperative period, using appropriate general an-
aesthetics; wider use of local anaesthetics, especially in
combination with general anaesthetics; minimising opera-
tive trauma; thorough intraoperative fluid management to
avoid intraoperative hemodynamic changes and maintaining
constant body temperature.
3. In the postoperative period, effective postoperative anal-
gesia using a multimodal approach, appropriate postopera-
tive environment, early postoperative mobilisation, early
enteral nutrition and probiotic use.
The appropriate use of these strategies can decrease the
stress response to surgery and facilitate patient recovery.
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PACIENTA ORGANISMA ATBILDE UZ ÍIRURÌISKO STRESU UN IESPÇJAMIE TÂS KOREKCIJAS VEIDI
Ir zinâmi divi galvenie pçcoperâcijas stresa sistçmiskie efekti: neiroendokrînais un hematoimunoloìiskais efekts. Neiroendokrînu atbildes
reakciju inducç hipotalâma–hipofîzes–adrenâlâs sistçmas un simpato-adrenâlâs–medulârâs sistçmas neironu aktivizâcija.
Hematoimunoloìisko atbildi raksturo citokînu produkcija, akûtas fâzes reakcija, limfocîtu un neitrofîlu leikocîtu proliferâcija. Visi
sistçmiski efekti ir cieði saistîti un cits citu ietekmç. Pârâk izteikta stresa atbildes reakcija var novest pie palielinâtas pçcoperâcijas
morbiditâtes un pasliktinât operâcijas iznâkumu. Íirurìisku stresu var ietekmçt preoperatîvi, perioperatîvi un postoperatîvi faktori. Rakstâ
apkopota literatûra par izmaiòâm organismâ, kuras notiek kâ atbildes reakcija uz íirurìisku stresu un apspriestas iespçjamâs stratçìijas, kâ
samazinât stresa atbildes reakciju un tâs ietekmi uz organismu.
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INTRODUCTION
Yeast expression systems are successfully used for produc-
tion of heterologous proteins and for generation of virus-
like particles (VLPs) of several sources (Strausberg and
Strausberg, 2001; Sasnauskas et al., 2002; Tsunetsugu-
Yokota et al., 2002; Chen et al., 2004; Juozapaitis et al.,
2005; Mach et al., 2006; Freivalds et al, 2011). Our particu-
lar interest is the potential of yeast cells as a host for pro-
ducing properly folded bacteriophage MS2, Q and GA
coat protein-derived VLPs (Legendre and Fastrez, 2005;
Freivalds et al., 2006; Freivalds et al., 2008; Rûmnieks et
al., 2008; Sun et al., 2011), also with simultaneously pack-
aged mRNAs in vivo (Legendre and Fastrez, 2005; Rûm-
nieks et al., 2008; Sun et al., 2011). Here we continue our
previous investigations (Freivalds et al., 2008; Rûmnieks et
al., 2008) in several aspects: 1) to improve the yield of
VLPs formed by GA coat protein in Saccharomyces
cerevisiae by use of optimised, yeast-characteristic codons,
2) to produce nanoparticles with in vivo packaged mRNAs
coding „reporter” protein GFP or interleukin-2, 3) to exploit
the two-promoter expression system pESC-URA for pro-
duction of mosaic particles formed from two proteins —
GA coat protein and this protein fused with the desired
eukaryotic sequence, this time with fragment of HIV Tat se-
quence and with West Nile Virus E protein DIII chain. Such
an approach to form mosaic particles often is the only possi-
bility to involve foreign protein sequences into soluble
structures and to utilise them in further investigations.
In our previous papers (Freivalds et al., 2008; Rûmnieks
et al., 2008), the GA coat protein (CP) encoding gene was
amplified from Escherichia coli expression plasmid
pGA-355-24. The CP aminoacid sequence encoded by this
plasmid is identical to that published by Tars et al., 1997.
The coding sequence for this plasmid was obtained by RT
of full-length bacteriophage GA RNA, and therefore, it
could be designated as original (Escherichia coli specific).
Previously it was shown (Freivalds et al., 2008) that the
highest yield of GA CP VLPs was obtained in the case of
yeast Pichia pastoris. In Saccharomyces cerevisiae, the
yield of GA CP-formed particles was lower — up to two
times for AH22/pFX-GA and remarkably low for YPH499/
pESCURA. Both Saccharomyces cerevisiae vectors exist in
cells as episomes. Our particular interest was vector
pESC-URA from Stratagene, which has two regulated pro-
moters Gal1 and Gal10 that are very powerfully induced by
galactose (up to 1000-fold). The Gal1 and Gal10 promoters
share a common upstream activating sequence, which tran-
scribe in opposite orientations and can be used to express
two products simultaneously and in approximately equiva-
lent amounts. To attempt to improve yield of GA
CP-derived particles, we decided to switch from original
Escherichia coli preferred codons to optimised ones for
yeast. It is considered that optimal codons can aid to
achieve faster translation rates and higher accuracy of those
processes. Optimal codons in fast-growing microorganisms,
like Escherichia coli or Saccharomyces cerevisiae, reflect
the composition of their respective genomic tRNA pool.
Preferred codon usage in E. coli and yeast is quite different
(Klump and Maeder, 1991). To convert the E. coli original
GA CP sequence into an optimal one for yeast, a built-in
Saccharomyces cerevisiae codon table from the Invitrogen
software package Vector NTI 10 was used. Additional cor-
rections were made by us to eliminate blocks with more
than four identical nucleotides. The resulting GA CP coding
sequence used in further work is displayed in Figure 1.
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Our previous research showed that the best yield of virus-like particles (VLPs) formed by RNA
bacteriophage GA coat protein was obtained by expression in yeast Pichia pastoris, while other
used expression systems in Saccharomyces cerevisiae gave much lower amounts of capsids.
The main reasons to attempt further studies in Saccharomyces cerevisiae were to improve the
yield of GA-based VLPs using constructs with optimised nucleotide triplets in coding sequences,
and to exploit the possibilities of the two-promoter Gal1/Gal10 system of expression vector
pESC-URA for production of the desired mosaic VLPs and for packaging of mRNAs into VLPs in
vivo.
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MATERIALS AND METHODS
Materials. The materials employed were: Anti-Inter-
leukin-2 Antikörper (online-antibodies GmbH); Pro-Q®
Diamond Phosphoprotein Gel Stain (Molecular Probes, In-
vitrogen); Shrimp Alkaline Phosphatase (Fermentas); pESC
Yeast Epitope Tagging Vectors (Stratagene); plasmid
pUC57-GA containing GA coat protein sequence encoded
with yeast optimized codons (GeneScript); Yeast Transfor-
mation Kit (Sigma) and First Strand cDNA Synthesis Kit
(Fermentas).
Plasmids and constructions. All used constructions made
by ligation of vectors and appropriate fragments (synthe-
sised in PCR reaction and digested with vector-consistent
restriction endonucleases), are summarised in Table 1. Two
S. cerevisiae plasmids with original GA CP gene sequences
were already available — pESC-GA was obtained from pre-
vious experiments (Freivalds et al., 2008) and pFX-GA was
a kind gift from Dr. Andris Kazâks (Freivalds et al., 2008).
Constructions with optimised codons were prepared on the
basis of those two plasmids:
(1) for expression in yeast AH22, the construction pAS66
was made by cutting the coat protein gene from plasmid
pUC57-GA and inserting it in the vector derived from
pFX-GA;
(2) for expression in yeast YPH499, constructions pAS65
and pIC971 were synthesised by cloning out the GA CP
coding sequence from plasmid pUC57-GA by PCR reaction
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Fig. 1. Comparison of GA CP original,
software generated and optimised
(manually corrected) codon sequences.
and inserting it in plasmid pESC-URA; other plasmids were
derived from those two plasmids.
Plasmid pIC562 was constructed to “stick” the West-Nile
virus envelope protein domain III (WNV-EDIII) sequence
to the C-terminus of Acinetobacter phage AP205 coat pro-
tein. The WNV-DIII sequence was cloned from
pTRHis2A-WNV plasmid (Martina et al., 2008), inserted in
vector plasmid pAP409 (Tissot et al., 2010) and expressed
in E. coli JM109 cells.
In the first step, to obtain mosaic virus-like particles, the
construction pIC929 was created in which GA CP se-
quences were inserted under control of both promoters
(Gal1 and Gal10). GA CP under control of Gal10 promoter
was C-terminally fused with the WNV-EDIII sequence,
which was cloned out from construction pIC562. In the case
of construction pDA21, pESC-GA plasmid (Freivalds et al.,
2008) was modified by inserting, under control of the Gal10
promoter, the GA CP gene that was previously N-terminally
prolonged with the HIV-Tat (48-60) sequence (from con-
struction pAK5 for expression in E. coli system). Therefore,
this construct was made with E. coli-specific codons.
For in vivo packaging, four constructions were made — two
with the interleukin 2 (IL2) sequence cloned from plasmid
pAC262 (Avots et al., 1990) and two with the eGFP se-
quence cloned from plasmid pCEP4-CXCR4-eGFP (Strods
et al., 2010). Each of the genes was cloned in GA CP con-
taining pESC-URA plasmid, under control of either under
Gal1 or Gal10 promoter.
Transformation and protein production. S. cerevisiae
strain AH22 competent yeast cells were transformed with
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appropriate plasmids (pFX or pAS66) and cultivated for GA
CP expression as described by Freivalds et al., 2008.
S. cerevisiae strain YPH499 competent cells were trans-
formed with appropriate pESC-URA plasmids by using
standard lithium acetate/polyethylene glycol procedure (by
using Yeast Transformation Kit (Sigma)) as described by
Gietz et al. (1992). Transformants were selected on uracil-
free agarised synthetic dextrose minimal medium (SDU-)
according to the manufacturer’s protocol. Analytic expres-
sion was performed for clone selection. For cell multiplica-
tion, 5 mL SDU- medium and incubation in 30 oC for 24 h
were used. For expression, 1 mL inoculum and 5 mL ura-
cil-free synthetic galactose minimal medium (SGU-) and in-
cubation in 30 oC, 200 rpm for 24 hours were used. Protein
content in cells was determined with Western blotting. Se-
lected clones were cultivated for preparative protein expres-
sion. 5 mL of inoculum were incubated in 100 mL SDU- in
30 oC, 200 rpm for 24 hours; the cells were collected by
centrifugation (3000 rpm, 5 min) and resuspended in 200
mL SGU- and cultivated for 48h. Preparative cultivation
was conducted in 1 L flasks.
Purification of VLPs. For purification, 3–8 grams of yeast
cells were resuspended in 10 mL of buffer solution B (20
mM Tris-HCl, 5 mM EDTA, 0.65 M NaCl, pH7.8) supple-
mented with 0.03 mM PMSF. For cell disruption, suspen-
sion was subjected to the French press (three strokes,
20 000 psi), then stirred with 5mL glass beads (Sigma) (30
sec of stirring and 1 min of cooling on ice, 15 cycles) and,
finally, sonicated with 22 kHz ultrasound (15 sec of
sonication and 1 min of cooling on ice, 5 cycles). Insoluble
cell debris was avoided by centrifugation (30 min, 12 000
rpm). The pellet wash (with 5 ml of buffer solution B) was
added to the previous supernatant for concentration by dial-
ysis against buffer solution B : glycerol (1 : 1) for 24 hours.
Concentrated material was loaded onto a Sepharose CL-4B
gelfiltration column (2 × 63 cm) with buffer solution B flow
rate approximately 2 mL⋅h-1.
Capsids were pooled and concentrated by addition of solid
ammonium sulphate to 60% of saturation and incubation
overnight at –18 oC. After centrifugation (15 min, 10 000
rpm), the sediment was solubilised into 1 mL buffer B and
dialysed against buffer TEN (20 mM Tris-HCl, 5 mM
EDTA, 0.15 M NaCl, pH7.8) with a lower amount of so-
dium chloride. Contaminant nucleic acids were removed by
passing through a short DEAE-Sephadex A50 ion-exchange
column according to Rûmnieks et al., 2008.
Final purification of VLPs was performed by sucrose den-
sity gradient ultracentrifugation on an ultracentrifuge Op-
tima L-100XP with SW32Ti rotor at 20 500 rpm 13 hours.
Centrifuge tubes were filled with layers of descending con-
centrations of sucrose solutions, starting with 36% on bot-
tom till 5% on top. After fractionation and analysis, capsids
were collected and dialysed against buffer solution B : glyc-
erol (1 : 1) and stored.
Analysis of incapsided nucleic acids. Nucleic acids from
0.2 mg of purified capsids were extracted using phenol as
described by Rûmnieks et al., 2008. Synthesis of the first
strand cDNA was conducted using the First strand cDNA
synthesis kit (Fermentas) according to the manufacturer’s
protocol; 1/10 of extracted RNA was used as a template for
each of the corresponding primers — random hexamers,
oligo(dT)18, forward primer against GA CP, and forward
primer against IL-2 or against eGFP gene sequence. For
second strand cDNA synthesis by PCR reaction, both for-
ward and reverse primers were added to 2 µL of each mix-
ture and products were analysed in agarose gel electropho-
resis (Fig. 5).
Polyclonal antibodies against West-Nile virus E protein
DIII sequence. Plasmid pIC562 was expressed in E. coli
JM109. After ultrasonification of cells in lysis buffer (10
mM Tris-HCl, 5 mM EDTA, 0.03 mM PMSF, pH7.8), solu-
ble proteins were removed by centrifugation at 12 000 rpm
for 45 min. Fusion protein P562 (AP205 CP – WNV EDIII
fragment) was extracted from the pellet with 7M urea in
water and placed on a column with DEAE-cellulose,
pre-equilibrated with 0.02 M Tris-HCl, pH8.6. Protein P562
did not absorb and was collected by washing out with equil-
ibration buffer and sedimented with equal volume of satu-
rated ammonium sulphate. For immunisation, a solution of
P562 in 7 M urea was prepared.
The immunisation of five Balb/c mice was conducted by si-
multaneous peritoneal and subcutaneous injections of 25 µg
of purified virus-like particles in total volume 200 mµL,
supplemented with complete Freund’s adjuvant (Sigma) in
equal amounts. Two re-immunisations were conducted after
14 and 28 days in the same manner, but by using incom-
plete Freund’s adjuvant (Sigma) instead of complete
Freund’s adjuvant. Mice were bled after 42 days and the
collected blood was incubated for 30 min at +37 °C and for
20 min at +4 °C. After centrifugation serum was collected
and mixed with glycerol (1 : 1) for storage in –20 °C.
Permission from the Food and Veterinary Service was ob-
tained.
Polyacrylamide gel elecrophoresis and Western blotting.
PAGE was performed in Tris-glycine buffer with 21% reso-
lution gel and 6% stacking gel, and bands were sil-
ver-stained according to standard procedure. Western-blots
were made with rabbit polyclonal anti – GA CP VLPs (as
an antigen for antibody production, GA CP VLPs produced
in E. coli (from construction pGA-355-24) and protein A –
HR peroxidase conjugate (Sigma)) were used.
RESULTS
A set of plasmids was created to construct GA CP-based
mosaic particles and to develop in vivo packaging of VLPs
with the desired mRNAs (Table 1). The advantage of the
used commercial expression system pESC-URA is it uni-
versality, which allows to manufacture plasmids in E. coli
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as a host and therefore to involve vectors for expression of
VLPs in bacteria. Table 2 represents sequences of oligo-
nucleotide primers used to create constructs for VLP pro-
duction. To check the effect of codon changes made in the
CP coding part of the plasmid on the production of GA CP
VLP, we compared yields of capsids with previously ex-
ploited construction pFX-GA and the new construct pAS66
(Table 1).
Previous work had shown that, comparing the used S. cere-
visiae systems AH22/pFX-GA and YPH499/pESC-URA,
the first of them, which was formaldehyde inducible, gave
slightly higher yield of particles (Freivalds et al., 2008).
Hence just this system was chosen to compare yield of the
product coded by the original E. coli-specific sequence and
our „improved” plasmid pAS66. Using pAS66 we obtained
stably higher yield of particles, the process became more re-
peatable, and production reached two milligrams per one
gram of yeast cells. Therefore, in our further constructs for
the system of interest YPH499/pESC-URA (uracil auxo-
trophy), new CP coding sequences were exploited, except-
ing construct pDA21 with E. coli origin codons (Table 3).
We focused on two-promoter system possibilities, rather
than on the yield of products, as it is well known that S.
cerevisiae prefers glucose as a carbon source and its growth
rate is much higher in glucose than in galactose-containing
media, which is necessary for activation of both promoters
in pESC-URA. In all cases investigated till now, yield of
purified capsids was at least 1 mg per gram of yeast cells.
Protein modifications can occur in yeast — particularly
phosphorylation, which can affect up to 30% of the
proteome (Ptacek et al., 2005) and usually affects serine
residues (Cobitz et al., 1989). Phosphorylation of GA CP in
our cases was not observed, which is surprising, as each
129-aminoacid-long GA CP molecule contains 14 serines.
In the cases of VLPs produced from plasmids pAS65,
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T a b l e 2
OLIGONUCLEOTIDE PRIMERS USED FOR THE CONSTRUCTION OF PLASMIDS AND RT-PCR
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T a b l e 3
CHARACTERISTICS OF CONSTRUCTIONS EXPRESSED IN THE





VLPs yields pAS65 GAL1 GA CP
pIC971 GAL10 GA CP
mosaic particles pDA21* GAL1
GAL10
GA CP























* both GA CP coding sequences are E. coli origin
pAS66, pIC930 and pIC958, two tests (proQ Diamond
phosphoprotein gel staining of CP in PAAG and incubation
with PME with subsequent electrophoresis of capsids in na-
tive agarose gel) did not show phosphorylation of GA (data
not shown). It is interesting that electrophoretic mobility of
GA CP-formed capsids from E. coli (355-24) and from
yeast (pIC930 and pIC972) was quite different in native
agarose gels compared with that of coat protein in PAAG
(Fig. 2C).
We attempted to obtain mosaic particles consisting of native
CP and of CP fused with foreign sequences. Two such con-
structs, pDA21 and pIC930, were successfully expressed
(Table 3). In both cases, N- terminal (DA21) and C-terminal
(IC930) (Fig. 2A) fusions were involved (Fig. 3A). Two
products were obtained: particles with HIV-1 Tat sequence
48-60 (Vivès et al., 1997) and with West Nile EDIII se-
quence (Martina et al., 2008) (Fig. 4A). Western-blot analy-
sis gave convincing evidence of mosaic particles, as besides
monomers and dimers of GA CP, also bands of fused pro-
longed coat protein (Fig. 2B) were evident. Construct ex-
pression in pESC-URA vector allowed to obtain the HIV-1
Tat 48-60 sequence for study as a cell membrane-transduc-
ing address. Similar particles obtained by expression in E.
coli were not formed (data not shown). However, use of an-
other similar construct, in which GA CP was N-terminally
fused with the vMIPII fragment (not shown) resulted in
capsids in E. coli, but not in yeast. Therefore, the use of
both bacterial and yeast expression systems allow us to
broaden the set of mosaic virus like particles.
While considering that in the future we need packaged GFP
mRNA as a reporter for delivery experiments, two sorts of
mRNAs were packaged under control of both promoters
that resulted in four constructions: two for packaging of
green fluorescent protein (GFP) mRNA (constructions
IC984 and IC921) and two for packaging of IL2 mRNA
(constructions IC958 un IC972). After accurate purification
of produced VLPs, including sucrose density gradient ultra-
centrifugation to avoid even traces of “stuck” nucleic acids,
capsids were treated with phenol and internal nucleic acid
was collected. Random hexamer primers indicate the total
RNA pool (Fig. 5, lines 1). Primer oligo(dT) allows to visu-
alise all mRNAs, as they have poly(A) tracts (Fig. 5, lines
2). The utilised experimental conditions allowed us to com-
pare amounts of mRNA by comparing material in specific
PCR product bands. Lines 3 (Fig. 5) showed negligible
amounts of GA coat protein mRNA, but cogent bands cor-
responding to GFP and IL2 coding sequences (Fig. 5, lines
4a–4d) demonstrated packaging of desired mRNAs in vivo
into particles.
DISCUSSION
Yeast provides a source of eukaryotic 5’-capped and
3’-poly(A)-tailed mRNAs, which is attractive considering
our goal to use GA VLPs as RNA packaging and delivery
tools in mammalian cells. Also, the absence of bacterial
endotoxins in yeast preparations is a good reason to choose
this system for in vivo packaging studies. In previous stud-
ies, genes of interest for packaging were inserted under con-
trol of the Gal10 promoter (Legendre and Fastrez, 2005;
Rûmnieks et al., 2008). We also used this method, but with
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Fig. 2. Analysis of VLPs by PAAG (A and B) and agarose gel (C) electro-
phoresis: A – silver staining of purified construction IC930 VLPs; B –
Western blotting of constructions 355-24 (1), IC930 (2) and DA21 (3); C –
purified VLPs from constructions 355-24 (1), IC930 (2) and IC972 (3).
Fig. 3. ELISA immunodetection: A – AS66 and IC930 VLPs with murine
polyclonal 562 antibodies against WNV EDIII; B – lysates from cells with
expressed construction pIC958 VLPs with anti-interleukin-2 antibodies;
displayed values are after subtraction of control (e.g., lysate from untrans-
formed YPH499 cells).
Fig. 4. Electronmicroscopy of mosaic VLPs – construction IC930 (A) and
of VLPs with packaged IL-2 mRNA - construction IC972 (B).
substituted constructions (Table 1, constructions pIC972
and pIC984). It was previously shown that packaging of
heterologous mRNAs into GA CP particles occurred inde-
pendently of the presence or absence of the specific
stem-loop operator sequence (Rûmnieks et al., 2008). This
is consistent with the rather low specificity of GA coat pro-
tein to structure of the operator (Gott et al., 1991) and ex-
plains the encapsidation of different RNAs. Even in the case
of MS2 coat protein, which is well known as to form stable
replicative complex I (coat protein + operator sequence of
RNA), encapsidation efficiency and specificity to a greater
extent affects the concentration of mRNA rather than its
source (Picket and Peabody, 1993). Therefore, we were in-
terested in examining the yield of GA CP particles and their
RNA packaging capacity and specificity by changing pro-
moters for expression of structural coat protein and corre-
sponding mRNA.
Interleukin-2 is a secreted cytokine that is important for T-
and B- lymphocyte proliferation. IL2 is produced by T-cells
in response to antigenic and mitogenic stimulation and is re-
quired for T-cell proliferation and other activities crucial to
regulation of the immune response. IL2 can stimulate
B-cells, monocytes, lymphokine-activated killer cells and
natural killer cells. Despite of unclear, even negative or con-
tradictory results, IL2 still remains a promising therapeutic
tool for melanoma and glioma treatment (Fenstermaker and
Ciesielski, 2004; Albertini et al., 2008). In VLPs packaged
IL2, mRNA is foreseen for local treatment, when VLPs will
be able to deliver it into cells. Beside the liposomal
intracellular delivery system (Pakunlu et al., 2006), RNA
phage MS2 coat protein formed particles were demonstrated
as candidates for delivery of mRNAs into eukaryotic cells
(Legendre and Fastrez, 2005; Sun et al., 2011). These stud-
ies suggest that we are on the path to creating a drug deliv-
ery vehicle based on GA coat protein capsids.
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GA APVALKA PROTEÎNA ATVASINÂTO MOZAIKÂLO VÎRUSIEM LÎDZÎGO DAÏIÒU EKSPRESIJA Saccharomyces cerevisiae
UN mRNS in vivo IEPAKOÐANA DAÏIÒÂS
Mûsu iepriekðçjie pçtîjumi parâdîjuði, ka lielâkais RNS bakteriofâga GA apvalka proteîna veidoto vîrusiem lîdzîgo daïiòu (VLD) ieguvums
ir ekspresçjot tâs raugos Pichia pastoris; savukârt, izmantojot Saccharomyces cerevisiae ekspresijas sistçmu, kapsîdu ieguvums ir daudz
mazâks. Divi galvenie mçríi turpmâkajâm studijâm raugos Saccharomyces cerevisiae bija paaugstinât GA apvalka proteîna veidoto VLD
ieguvumu, izmantojot konstrukcijas ar optimizçtu nukleotîdu tripletu sekvencçm, un izpçtît iespçjas, ko varçtu sniegt divu promoteru
Gal1/Gal10 saturoðs ekspresijas vektors pESC-URA vçlamo mozaîkveida VLD iegûðanai un mRNS iepakoðanai VLD in vivo.
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INTRODUCTION
The Contingent of the International Operations appears to
be subject to various extreme factor actions, which can
cause Posttraumatic Stress Disorder (PTSD). PTSD is an
anxiety disorder that can develop after exposure to one or
more traumatic events, threatening or causing great physical
harm; it is a complex of symptoms experienced by survi-
vors of traumatic stress (Satcher, 2000). General PTSD
symptoms occur in complex psycho-physiological hypertro-
phic responses: intrusive experiences of a traumatic event,
illusions, hallucinations, persistent avoidance of stimuli as-
sociated with trauma, and general emotional numbness,
which are present for a period of at least one month. Clini-
cal diagnosis of PTSD, according to the Diagnostic and Sta-
tistical Manual of mental disorders (DSM-IV-TR), is per-
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Communicated by Rafails Rozentâls
Increased excitotoxity in response to stressors leads to oxidative stress (OS) due to accumulation
of excess reactive oxygen/nitrogen species. Neuronal membrane phospholipids are especially
susceptible to oxidative damage, which alters signal transduction mechanisms. The Contingent of
International Operations (CIO) has been subjected to various extreme stressors that could cause
Posttraumatic Stress Disorder (PTSD). Former studies suggest that heterogeneity due to gender,
race, age, nutritional condition and variable deployment factors and stressors produce challenges
in studying these processes. The research aim was to assess OS levels in the PTSD risk group in
CIO. In a prospective study, 143 participants who were Latvian CIO, regular personnel, males,
Europeans, average age of 27.4, with the same tasks during the mission, were examined two
months before and immediately after a six-month Peace Support Mission (PSM) in Afghanistan.
PCL-M questionnaire, valid Latvian language “Military” version was used for PTSD evaluation.
Glutathione peroxidase (GPx), superoxide dismutase (SOD) and lipid peroxidation intensity and
malondialdehyde (MDA) as OS indicators in blood were determined. Data were processed using
SPSS 20.0. The MDA baseline was 2.5582 µM, which after PSM increased by 24.36% (3.1815
µM). The GPx baseline was 8061.98 U/L, which after PSM decreased by 9.35% (7308.31 U/L).
The SOD baseline was 1449.20 U/gHB, which after PSM increased by 2.89% (1491.03 U/gHB).
The PTSD symptom severity (total PCL-M score) baseline was 22.90 points, which after PSM in-
creased by 14.45% (26.21 points). The PTSD Prevalence rate (PR) baseline was 0.0357, which
after PSM increased by 147.06% (0.0882). We conclude that there is positive correlation between
increase of OS, PTSD symptoms severity level, and PTSD PR in a group of patients with risk of
PTSD – CIO. PTSD PR depends on MDA intensity and OS severity. OS and increased free radi-
cal level beyond excitotoxity, is a possible causal factor for clinical manifestation of PTSD.
Key words: Posttraumatic stress disorder, oxidative stress.
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formed by means of a clinical PTSD checklist PCL-M
(military version). PCL-M includes 17 items. It is recom-
mended for use as an objective diagnostic tool for examina-
tion of patients with PTSD and PTSD risk group patients
(Anonymous, 2000; Weathers et al., 2001; Watson et al.,
2005; Pynoos et al., 2009; McDonald and Calhoun, 2010).
According to available literature data, the PTSD level be-
fore Peace Support Missions has been reported as high as
2.4–9.3% in the American Contingent of the International
Operations (Hoge et al., 2004; Riddle et al., 2007) and
2.4% in the British Contingent of the International Opera-
tions (Iversen et al., 2009). PTSD level after Peace Support
Mission is reported as 11.2% in the American Contingent of
the International Operations (Hoge et al., 2004) and
4.0–9.5% in the British Contingent of the International Op-
erations (Hotopf et al., 2006; Iversen et al., 2009).
Pathophysiology and pathogenesis of PTSD is associated
with excitotoxity. Excitotoxity is the pathological process
by which neurons are damaged due to hyperactivations of
the excitatory neurotransmitter glutamate (Li et al., 2001,
Jourdain et al., 2007). Excitotoxity-activated microglia cells
appear to become probable sources of chronic oxidative
processes leading to oxidative stress (Anwyl, 1991).
Neuronal membrane phospholipids are especially vulnera-
ble to damage; the injury leads to the receptor-mediated sig-
nal transduction and, furthermore, information processing
disorders. Studies on the effects of hyperoxidation, oxida-
tive and carbonyl stresses on cerebral suppression and its re-
lation to brain degeneration with respect of neuronal func-
tions are of great interest and importance. Indeed there are
difficulties in rating and interpreting of available literature
data, as the studies are inhomogeneous in gender, race, age,
nutritional and deployment factors — reservists or regular
personnel, and different stressful military experiences in
various Peace Support Missions.
Oxidative stress intensity was assessed considering the ma-
londialdehyde (MDA) plasma level. Unsaturated carbonyl
MDA is one of the most frequently used direct indicators of
lipid peroxidation. MDA measurement appears to be a suit-
able quantification method of the end-products of lipid
peroxidation. The production of MDA is used as a bio-
marker to measure the level of OS in an organism and is of-
ten used in oxidative stress studies (Moore and Roberts,
1998; Del Rio et al., 2005; Nie et al., 2007). MDA is a nat-
urally occurring metabolic product of polyunsaturated fat
degradation (lipid peroxidation), and has been reported to
be mutagenic and carcinogenic. Free radical damage to
lipids results in MDA reacting with DNA to form adducts to
deoxyguanosine and deoxyadenosine and releasing an inter-
mediate product of formaldehyde (Nie et al., 2007). Formal-
dehyde at low concentrations induces protein misfolding
causing a high cytotoxic aggregation. As a metabolic prod-
uct, MDA might weaken cerebral function during oxidative
stress through breaking the homeostasis between excitatory
and inhibitory neurons. Being less active than other free
radical, MDA has a rather longer half-life and, thereby, can
diffuse from the generation places to other sites, bringing
further oxidative stress. Cells are equipped with enzymatic
and nonenzymatic antioxidant systems to eliminate
ROS/RNS and maintain redox homeostasis. A major class
of enzymatic antioxidants, which catalyze the dismutation
of superoxide into oxygen and hydrogen peroxide, is known
as superoxide dismutase (SOD). Multiple isoforms of SOD
exist in different cellular compartments. SOD1 (CuZnSOD)
is the major superoxide scavenger found in the cytoplasm,
mitochondrial intermembrane space, nucleus, and lyso-
somes, whereas SOD2 (MnSOD) and SOD3 are found in
the mitochondria and extracellular matrix, respectively. In-
deed, they impart an important antioxidant defence system
and their activity increases upon oxidative stress. Some
SOD isoforms resulting from oxidative stress have been
linked with human diseases. Thus, mutations in the CuZn-
SOD can result in familial amyotrophic lateral sclerosis
(Milani et al., 2011). Further conversion of hydrogen perox-
ide occurs through the action of catalase, a heme-based en-
zyme that is normally localised in the peroxisome. Hydro-
gen peroxide also can be converted to oxygen through
coupled reactions with the conversion of reduced glu-
tathione to oxidized glutathione, catalysed by glutathione
peroxidase (GPx). The main biological role of GPx is to
protect the organism from oxidative damage. The biochemi-
cal function of GPx is to reduce lipid hydroperoxides to al-
cohols as well as to reduce free hydrogen peroxide to water
(Miyamoto et al., 2003). GPx scavenges extremely active
hydroxyl radicals without formatting toxic adverse prod-
ucts. GPx is present in a high concentration in the cells and
plays a crucial role in ensuring them in a reduced state. The
GPx role as antioxidant is particularly important for brain,
as it is very sensitive to presence of free radicals. Insuffi-
cient GPx amount and/or activity can complicate oxidative
stress. Five isoforms of selenium (Se)-dependent GPx are
found in humans. Furthermore, enzymes such as glutathione
S-transferases are known to have Se-independent peroxi-
dase activity. Nonenzymatic antioxidants (thioredoxin,
glutaredoxins, peroxiredoxins), recognised to execute thiol–
disulfide exchange reactions, also play a major role in main-
taining cellular redox balance (Trachootham et al., 2008).
Our research aim was to assess oxidative stress levels PTSD
and their correlation in the Contingent of the International
Operations.
MATERIALS AND METHODS
The prospective study was conducted in the Department of
Psychosomatic Medicine and Psychotherapy, Rîga Stradòð
University (Rîga, Latvia) in close cooperation with the Bio-
chemical Laboratory (Rîga, Latvia) and Department of In-
ternal Diseases (Rîga, Latvia) of Rîga Stradiòð University,
and Medical Care Centre of the National Armed Forces
(Rîga, Latvia). The protocol of study, the protocol of agree-
ment, and the protocol of participation corresponded to the
Helsinki declaration on principles of humanity in medicine.
The study design was approved by the Ethics Committee
of Rîga Stradiòð University, protocol No. E-9(2) of
17.12.2009. For our research we used a participant group
with the highest possible level of homogeneity to avoid dif-
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ficulties in rating and interpreting of results. In total there
were 143 male European participants, average age 27.4,
regular military personnel, participants of the Latvian Con-
tingent of the International Operations. Examination was
performed before and after the same Peace Support Mission
in Afghanistan (six months), with the same tasks during the
mission. Clinical examination and laboratory parameters as-
sessment were taken twice: two months before the mission
(BL) and immediately after the mission (PL).
Clinical examination was made according to the diagnostic
pattern DSM-IV-TR (Anonymous, 2000). The following di-
agnostic criteria were assessed:
Criterion A: Stressor. The person has been exposed to a
traumatic event in which both of the following have been
present:
1. The person has experienced, witnessed, or been con-
fronted with an event or events that involve actual or
threatened death or serious injury, or a threat to the phys-
ical integrity of oneself or others;
2. The person's response involved intense fear, helplessness,
or horror.
Criterion B: Intrusive recollection. The traumatic event is
persistently re-experienced in at least one of the following
ways:
1. Recurrent and intrusive distressing recollections of the
event, including images, thoughts, or perceptions;
2. Recurrent distressing dreams of the event;
3. Acting or feeling as if the traumatic event were recurring
(includes a sense of reliving the experience, illusions,
hallucinations, and dissociative flashback episodes, in-
cluding those that occur upon awakening or when intoxi-
cated);
4. Intense psychological distress at exposure to internal or
external cues that symbolise or resemble an aspect of the
traumatic event;
5. Physiologic reactivity upon exposure to internal or exter-
nal cues that symbolise or resemble an aspect of the trau-
matic event.
Criterion C: Avoidant/numbing. Persistent avoidance of
stimuli associated with the trauma and numbing of general
responsiveness (not present before the trauma), as indicated
by at least three of the following:
1. Efforts to avoid thoughts, feelings, or conversations asso-
ciated with the trauma;
2. Efforts to avoid activities, places, or people that arouse
recollections of the trauma;
3. Inability to recall an important aspect of the trauma;
4. Markedly diminished interest or participation in signifi-
cant activities;
5. Feeling of detachment or estrangement from others;
6. Restricted range of affect (e.g., unable to have loving
feelings);
7. Sense of foreshortened future (e.g., does not expect to
have a career, marriage, children, or a normal life span).
Criterion D: Hyper-arousal. Persistent symptoms of increas-
ing arousal (not present before the trauma), indicated by at
least two of the following:
1. Difficulty falling or staying asleep;
2. Irritability or outbursts of anger;
3. Difficulty concentrating;
4. Hyper-vigilance;
5. Exaggerated startle response;
Criterion E: Duration. Duration of the disturbance (symp-
toms in B, C, and D) is more than one month.
Criterion F: Functional significance. The disturbance causes
clinically significant distress or impairment in social, occu-
pational, or other important areas of functioning.
PCL checklist was worked out at PTSD National Centre,
USA in 1993. The PCL has a variety of purposes, including
screening individuals for PTSD, diagnosing PTSD, moni-
toring symptom change during and after treatment. There
are three versions of the PCL: PCL-C (civilian), PCL-M
(military) and PCL-S (specific). PCL-M asks about symp-
toms in response to “stressful military experiences” and is
used for active service members and veterans (Weathers et
al., 2001; Watson et al., 2005; McDonald and Calhoun,
2010). The PTSD Checklist (PCL) is a 17-item self-report
measure of the 17 DSM-IV symptoms of PTSD. Respon-
dents are asked about certain troubles during the last month;
the answers are evaluated by a 5-point scale. The valid Lat-
vian language PCL-M version was used for objective PTSD
evaluation (Voicehovskis et al., 2011). PTSD risk group In-
cidence rate (IR) was also assessed.
Laboratory assessment of oxidative stress parameters in
blood included: intensity of lipid peroxidation assessed by
malondialdehyde (MDA) concentration and activity of anti-
oxidant enzymes: glutathione peroxidase (GPx) and super-
oxide dismutase (SOD). Blood samples were taken from all
individuals in morning at 8.00 (before meal). Venous blood
was collected into a vacutainer (Venoject II BD) containing
lithium/heparin as an anticoagulant.
Activity of glutathione peroxidase 3 (GPx), Enzyme Com-
mission number (EC) 1.11.1.9, was determined in heparin-
ised whole blood by the method of Paglia and Valentine
(Paglia and Valentine, 1967) using commercial tests manu-
factured by Randox Laboratories (UK, Antrium) in a RX
Daytona analyser. GPx catalyses the oxidation of gluta-
thione (GSH) by cumene hydroperoxide. In the presence of
glutathione reductase and nicotinamide adenine dinucleo-
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tide phosphate (NADPH) the oxidised glutathione (GSSG)
is immediately converted to the reduced form with a con-
comitant oxidation of NADPH to the oxidised NADP+. The
decrease in absorbance at 340 nm is measured. In the pres-
ence of hydroperoxide, GPx catalyses oxidation of GSH to
GSSG. The latter (GSSG) undergoes NADPH-dependent
reduction to GSH catalysed by glutathione reductase. This
reaction is accompanied by NADPH oxidation to NADP+.
Thus, activity of GPx corresponds to the decrease in absorb-
ance at 340 nm induced by NADPH oxidation and one unit
of enzyme activity is defined as the enzyme content re-
quired for oxidation of 1.0 µmol of NADPH per 1 min at
340 nm and 37 °C.
Malondialdehyde (MDA) level in plasma was measured as
suggested by Gavrilov (Ãàâðèëîâ è äð., 1987): at low pH
and elevated temperature, MDA readily participates in
nucleophilic addition reaction with 2-thiobarbituric acid
(TBA), generating a red 1:2 MDA: TBA adduct. The reac-
tion products was extracted with butanol and estimated at
535 nm and 580 nm by spectrophotometry.
The determination of superoxide dismutase (SOD, EC
1.15.1.1) employed xantine and xantine oxidase to generate
superoxide radicals that react with 2-(4-iodophenyl)-3-(4-
nitrophenol)-5-phenyltetrazolium chloride to form a red for-
mazan dye (Woolliams et al., 1983). The SOD activity was
then measured by the degree of inhibitation of this reaction.
Data were processed using SPSS 20.0. Statistical signifi-
cance of mean values was evaluated by means of the
Paired-Samples T-Test and one-Sample Kolmogorov-
Smirnov test. Interrelationship between parameters was eval-
uated by the Wilcoxon correlation coefficient; differences
were considered as statistically significant at P < 0.05.
RESULTS
The main results before PSM (BL) and after (PL) the mis-
sion are represented in the Table 1.
Baseline PTSD Prevalence rate (PR) was 0.0357, which af-
ter PSM PTSD PR increased by 147.06% to 0.0882 units
(Table 2).
Baseline MDA plasma level (MDA BL, see Fig. 1) was
2.5582 µM, which after PSM MDA level (MDA PL) in-
creased by 24.36% till 3.1815 µM (Fig.2).
Baseline GPx activity (GPx BL, see Fig. 3) was 8061.98
U/L, which after PSM GPx level (GPx PL) decreased by
9.35% till 7308.31 U/L (Fig. 4).
Baseline SOD plasma activity (SOD BL, see Fig. 5) was
1449.20 U/gHB, which after PSM SOD (SOD PL) in-
creased by 2.89% till 31491.03 U/gHB (Fig. 6).
Baseline PTSD symptom severity (PCL-M score, points,
BL, see Fig. 7) total score was 22.90 PCL-M points, after
PSM PCL-M score increased by 14.45% to 26.21 points
(Fig. 8).
A negative correlation was found between MDA and GPx
(Fig. 9).
DISCUSSION
Prevalence of oxidation processes accompanied by antioxi-
dant defence system failure leads to the development of oxi-
dative stress, which is one of the universal mechanisms of
tissue damage. Enzymatic activity of antioxidant systems
(catalase, SOD, glutathione peroxidase) in the brain is sig-
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T a b l e 1
THE MAIN RESULTS BEFORE (BL) AND AFTER (PL) THE PEACE SUPPORT MISSION (PSM) (one-sample Kolmogorov-Smirnov test)
Parameters N of partici-
pants
Normal parameters 1 Most extreme differences K-S Z2 AS3
Mean SD Abs. Poz. Neg.
GPx, BL, U/L 106 8061.98 1369.116 ,061 ,061 -,048 ,623 ,832
GPx, PL, U/L 29 7308.31 1129.871 ,123 ,092 -,123 ,661 ,775
SOD, BL, U/gHB 106 1449.20 137.173 ,049 ,039 -,049 ,503 ,962
SOD, PL, U/gHB 29 1491.03 121.739 ,219 ,219 -,116 1.181 ,123
MDA, BL, µM 49 2.5582 ,63475 ,067 ,067 -,057 ,467 ,981
MDA, PL, µM 13 3.1815 ,68560 ,125 ,125 -,092 ,450 ,987
PCL, BL, points 140 22.90 6.734 ,190 ,149 -,190 2.254 ,000
PCL, PL, points 34 26.21 9.247 ,201 ,201 -,160 1.172 ,128
PTSD, BL, PR+1 140 1.04 ,186 ,540 ,540 -,424 6.393 ,000
PTSD, PL, PR+1 34 1.09 ,288 ,532 ,532 -,380 3.103 ,000
1 Test distribution is normal; calculated from data; 2 Kolmogorov-Smirnov Z; 3 asymptotic significance; SD, standard deviation; GPx, glutathione peroxidase;
SOD, superoxide dismutase; MDA, malondialdehyde; PTSD, Posttraumatic Stress Disorder; PCL-M, PTSD Checklist – Military Version
T a b l e 2
PTSD MORBIDITY BEFORE (BL) AND AFTER (PL) THE MISSION








BL gr. 143 27.36 97.90 0.0357 -
PL gr. 37 26.20 91.89 0.0882 0.1765
PTSD, Posttraumatic Stress Disorder
nificantly lower than in other tissues. Oxygen radicals (hav-
ing oxygen with an unpaired electron) are superoxide anion
and hydroxyl radical. These are extremely aggressive. Glu-
tamate is a substrate that is able to support maximal H2O2
production rates by means of [Ca
2+
] mediated excitotoxity.
Scavengers of free radicals are located in the cytoplasm or
on cell membranes; these are mainly substances with low
molecular weight: superoxide dismutase, glutathione, glu-
tathione peroxidase, catalase, ceruloplasmin, vitamin A, vi-
tamin E, vitamin C, vitamin K, flavonoids, and coumarins.
Lipid peroxidation plays a crucial role in brain injury. The
brain contains a large amount of lipids (50% in a dry mat-
ter); most of them appear to be unsaturated and become
substrates for lipid peroxidation. Phospholipids account for
over half of all lipids of nervous tissue. Fatty acid and phos-
pholipids determine structural and functional features of
cell membranes, and contribute to its penetration and den-
sity. Lipid peroxidation of any intensity results in functional
brain disorder (Esterbauer and Cheeseman, 1990; Ginsberg
and Bogousslauvsky, 1998). Moreover, it could become a




Fig. 2. Relationship of malondialdehide (MDA) before (BL) vs MDA after
the mission (PL).
Fig. 3. Glutathione peroxidase level
distribution before the mission.
cause of structural and morphological alterations, and de-
generation processes.
The PTSD patients note problems in cognition (memory, at-
tention), somatic concerns (headache), and affective deregu-
lation (impulsivity, irritability, anxiety), particularly in the
time period shortly after the traumatic event (whether psy-
chological, biomechanical, or both). A biochemical mecha-
nism associated with elevated levels of oxidative stress pa-
rameters has been proposed to explain the etiology of PTSD
(common etiology of posttraumatic stress disorder, fibromy-
algia, chronic fatigue syndrome and multiple chemical sen-
sitivity) (Pall, 2001; Pall and Satterlee, 2001; Pall, 2007;
Adibhatla and Hatcher, 2008). Alterations of glutamatergic
and NMDA receptor functions play a role in the etiology of
PTSD in humans. Some clinical studies have observed a
marked increase of cerebral neurotransmitter glutamate in
PTSD (Moghaddam et al., 1994; Chambers et al., 1999;
Cortese and Phan, 2005). Stress increases glutamate release,
which is recognised as an important mediator of excitotox-
ity. Since a prominent role of glutamate-related excitotoxity
followed by neuronal damage, glutamatergic pathways may
have an important role in stress-related hippocampal degen-
erative pathology and cognitive deficits seen in patients
with PTSD (Moghaddam et al., 1994). Brain imaging stud-
ies have revealed a marked reduction in hippocampal vol-
ume (Sapolsky, 2000; Reul and Nutt, 2008). Such morpho-
logical alterations appear to be positively correlated with
the degree of cognitive deficit noted in these patients.
PTSD-induced oxidative stress has been proposed to occur
in this disorder. Recent clinical studies confirmed the in-
volvement of neurodegenerative pathology in the PTSD
pathogenesis (Bremner, 2002). Neurochemically-mediated
damage could be conceivably related to neurohumoral dys-
regulation.
The main conclusions are:
1. MDA intensity increased during PSM; MDA intensity re-
flects the rate of lipid peroxidation and OS severity.
247Proc. Latvian Acad. Sci., Section B, Vol. 66 (2012), No. 6.
Fig. 4. Glutathione peroxidase before (BL) vs after the mission (PL).
Fig. 5. Superoxide dismutase
level distribution before the
mission.
Fig. 6. Superoxide dismutase (SOD) before (BL) vs after the mission (PL).
2. GPX activity is decreased in the PTSD risk group and is
not efficient to overwork and/or control OS.
3. SOD activity is increased in the PTSD risk group but is
not efficient to overwork and/or control OS.
4. There is positive correlation between increase of oxida-
tive stress – MDA level, PTSD symptom severity level,
and PTSD Prevalence rate (PR) in the studied group of
patients with risk of PTSD (Contingent of the Interna-
tional Operations). PTSD PR depends on MDA intensity
and OS severity.
Our results suggest that the production of free radicals re-
sulteing in lipid peroxidation seemed to be related to PTSD.
The present results showed that patients with PTSD differed
from healthy controls in both antioxidant system activity
(GPx, SOD) and lipid peroxidation (MDA) level. Therefore,
we conclude that OS, increased free radical level beyond
excitotoxity, is a possible causal factor for clinical manifes-
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list – Military Version
Fig. 8. PCL-M score before (BL) vs after the mission (PL).
PCL-M, Posttraumatic Stress Disorder Checklist – Military Version
Fig. 9. Negative correlation between MDA and GPx.
MDA, malondialdehyde; GPx, glutathione peroxidase
tation of PTSD. Our results need to be confirmed by more
comprehensive and detailed further studies to support the
findings we found in PTSD.
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OKSIDATÎVÂ STRESA PARAMETRI POSTTRAUMATISKÂ STRESA SINDROMA RISKA GRUPAS PACIENTIEM
Paaugstinâts eksaitotoksicitâtes lîmenis kâ atbildes reakcija uz stresoriem lieka reaktîvâ skâbekïa/slâpekïa uzkrâðanâs rezultâtâ izraisa
oksidatîvo stresu (OS). Neironâlo membrânu fosfolipîdi ir îpaði jutîgi pret oksidatîvo bojâjumu, rezultâtâ mainot signâlu pârneses
mehânismu. Starptautisko operâciju kontingents (SOK) tiek pakïauts daþâdiem ekstremâliem stresoriem, kas varçtu izraisît posttraumatiskâ
stresa sindromu (PTSS). Pieejamie pçtîjumu dati nav viendabîgi pçc dzimuma, rases, vecuma, uztura un daþâdiem dienesta faktoriem un
stresoriem, kas apgrûtina to salîdzinâðanu. Pçtîjuma mçríis: novçrtçt OS lîmeni PTSS riska grupâ. Pçtîjumâ piedalîjâs 143 dalîbnieki —
Latvijas SOK, regulârais militârais personâls, vîrieði, eiropieði, kuru vidçjais vecums ir 27,4 gadi, ar vienâdiem uzdevumiem misijas laikâ
— tika izmeklçti divus mçneðus pirms un uzreiz pçc seðu mçneðu ilgas Miera uzturçðanas misijas (MUM) Afganistânâ. PTSS novçrtçðanai
izmantota PCL-M anketa, apstiprinâta latvieðu valodas “militârâ” versija. Asinîs noteikti OS râdîtâji: glutationa peroksidâze (GPx),
superoksîda dismutâze (SOD) un lipîdu peroksidâciju intensitâtes râdîtâjs — malondialdehîds (MDA). Dati tika apstrâdâti, izmantojot SPSS
20.0. MDA bâzes lîmenis (2,5582 µM) pçc MUM pieauga par 24,36% (3,1815 µM). GPx bâzes lîmenis (8061,98 U/L) pçc MUM
samazinâjâs par 9,35% (7308,31 U/L). SOD bâzes lîmenis (1449,20 U/gHB) pçc MUM palielinâjâs par 2,89% (1491,03 U/gHB). PTSS
simptomu smaguma (PCL-M punktu skaits) bâzes lîmenis bija 22,90 punkti, pçc MUM tas palielinâjâs par 14,45% (26,21 punkts). PTSS
izplatîbas koeficienta (IK) bâzes lîmenis bija 0,0357, pçc MUM tas pieauga par 147,06% (0,0882). Autori secina, ka pastâv pozitîva
korelâcija starp OS pieaugumu, PTSS simptomu smaguma pakâpes lîmeni un PTSS IK pacientiem PTSS riska grupâ (SOK). PTSS IK ir
atkarîgs no MDA lîmeòa un OS smaguma. Iespçjams, ka OS un eksaitotoksicitâtes rezultâtâ palielinâtais brîvo radikâïu lîmenis ir veicinoðs
faktors PTSS klîniskâs izpausmes attîstîbai.
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INTRODUCTION
Gonadotropic hormone (GTH, gonadotropin; 25 kDa) of
sturgeon Acipenser güldenstädti Br., like mammalian gon-
adotropins, has heterodimeric molecular structure built of
two complementary non-covalently bonded  and  sub-
units (GTH and GTH) (Burzawa-Gerard et al., 1980;
Çåíêåâè÷ è äð., 1982; Zenkeviès, 1994). Individual GTH
and GTH have no hormonal function. Specific biological
activity typical for the native hormone is expressed only
after complementary self-reassociation of the counterpart
subunits in the – dimer structure. Reassociated from the
subunits, GTH dimer usually maintains up to 100% of
immunoreactivity and by about 70% of hormonal function
typical of the native hormone.
In the course of comparative investigations of GTH and
GTH it was found that the subunits differed considerably
from each other by their negative molecular charge. The
electrophoretic mobility (Rf) of GTH (Rf 0.41–0.58) in
7.5% polyacrylamide gel towards the anode was consider-
ably higher than that of the positively charged GTH (Rf
0.05–0.15) (Zenkeviès, 1994; Zenkeviès et al., 2003). This
indicated that GTH (three COOH groups) contains a pre-
dominance of positive molecular charge, unlike GTH.
Also, as it was previously shown, GTH has a rigid confor-
mation stabilised by six intramolecular S–S-bonds, while
the conformationally flexible GTH contains only one
S-S-bond (Zenkeviès, 1994).
Comparative investigation of the structural-functional role
of gonadotropin subunits provided evidence that GTH is
highly conserved within different higher and lower verte-
brate species, including fish, while GTH differs and im-
parts the species-specificity to the – dimeric structure of
the hormone (Licht et al., 1977; Pierce and Parsons, 1981;
Burzawa-Gerard, 1982). The same was found in studies of
properties of cross-recombinants of the counterpart subunits
from systematically very distant sturgeon GTH and pig LH
(Çåíêåâè÷ è äð.1982; Zenkeviès et al., 1999). On the basis
of these findings we supposed that the pronounced negative
molecular charge and the conformational rigidity of the
sturgeon GTH may serve as a core imparting charge,
three-dimensional spatial structure and the biological prop-
erties to the – heterodimeric molecule of the hormone.
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Free negatively charged carboxyl groups (COOH) were selectively modified (neutralised) in stur-
geon (Acipenser güldenstädti Br) gonadotropic hormone (GTH) -subunit (GTH). Eight COOH
groups were neutralised by reaction with glycine ethyl ester. Investigation of modified GTH
showed that specific immunoactivity with antiserum raised against standard GTH was com-
pletely lost. Analysis of CD spectra and the content of secondary structure elements of standard
and modified GTH did not indicate any considerable differences. Investigation of reassociated
– dimer comprising standard GTH and modified GTH showed that hormonal activity was
completely lost while immunoreactivity was lowered by about 30% in comparison with that of the
standard subunit – dimer. It was concluded that eight free COOH groups located on the sur-
face of GTH are the main structural components of the species-specific antigenic determinant
groups of the subunit, but are not directly involved in either maintaining the conformation of the
subunit nor in its ability to interact with the native counterpart subunit. COOH groups, as bearers
of the negative charge located on the surface of GTH, play a decisive role in the specific hor-
monal activity of GTH determined by oocyte maturation tests. Free COOH groups are included in
the effector zones (active sites) of GTH dimer molecule responsible for the stereospecific interac-
tion with the test-oocyte membrane hormone-sensitive binding (receptor) sites to induce the bio-
logical effects.
Key words: sturgeon fish gonadotropic hormone, -subunit, chemical modification, CD-spectro-
scopy, gonadotropic and immunologic properties.
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The aim of the present work was to employ selective chemi-
cal modification of the accessible free COOH groups of Asp
and Glu located in the GTH to elucidate their possible role
in maintaining the conformation of the subunit and the spe-
cies-specific functional properties of the – dimer hor-
mone molecule.
MATERIALS AND METHODS
Individual GTH and GTH of highly purified sturgeon
GTH (Çåíêåâè÷, 1992) were isolated by ion-exchange chro-
matography on SE-Sephadex C-25 in 0.025 M acetate
buffer at pH 4.9, after GTH dissociation into subunits in 8
M urea according to Hennen et al. (1971).
Self-reassociation or recombination of the counterpart
subunits was carried out in saline (0.9% NaCl) at room tem-
perature (12 h) at a total protein concentration of about
0.2%, using the subunits in an equimolar ratio.
Polyacrylamide gel (7.5%) electrophoresis (PAGE) was car-
ried out in gel slabs (0.4 × 9 × 10 cm), using TRIS-Gly
buffer solution at pH 8.9 (Davis, 1962). Protein bands were
stained with Coomassie Brilliant blue R-250.
Free COOH groups of GTH were modified by glycine
ethyl ester (Gly-OEt·HCl) in the presence of water soluble
1-ethyl-3(3-dimethylaminopropyl) carbodiimide (Serva) at
pH 4.8 in distilled water for 30 min at room temperature ac-
cording to the procedure described earlier (Eyl et al., 1970;
Faith and Pierce, 1975). In such a way the negative charge
of free carboxyl groups of the subunit were converted to
their O-glycine ethyl esters (neutralised). The reaction was
stopped and modified subunit was separated from the reac-
tion by-products on minicolumns (0.9 × 10.5 cm) of
Sephadex C-25 in 2% acetic acid and lyophilised. The num-
ber of modified COOH groups of the GTH was deter-
mined by amino acid analysis (Mikrotehna Praha, Czech
Rep.).
To produce antisera against GTH and GTH young rabbits
were injected subcutaneously and intramuscularly with the
preparations (0.2 mg/injection) in saline using complete
Freund`s adjuvant (Calbiochem, USA) for ten weeks.
Double immunodiffusion tests in 1% agar gel (Bacto-agar
Difco, USA) in veronal buffer (ionic strength 0.05, pH 8.6)
were performed by a classical procedure (Ouchterlony,
1958) using polyclonal monovalent antisera. The immuno-
reactivity as a percent of the standard and modified prepara-
tions was calculated as the inverse proportion between the
numbers of active double dilutions.
The frog Rana temporaria L. oocyte in vitro maturation test
(Thornton, 1971) was used to evaluate (to compare) the hor-
monal activity of the reassociated a– dimers comprising
COOH-modified or intact GTH. The activity was ex-
pressed as the minimal dose of the tested hormone prepara-
tion that produced 50% test-oocyte maturation (D50).
CD spectra of the standard and COOH-modified GTH
were registered on a Jasco J-710 spectropolarimeter over
the wavelength range from 180 to 250 nm at 22–25 °C, in
phosphate buffer, pH 7.0. The spectropolarimeter was cali-
brated by epiandrosterone and 10-camphor-sulphonic acid
standards. For recording of spectra, 0.1–0.01 cm Helma
quartz cells were used. The concentration of protein in the
solution was 10-3–10-4 M. CD data are given in units of mo-
lar ellipticity per amino acid residue of an average relative
molecular mass 108. The content of various secondary
structures in the subunits was calculated using the CDPro –
CONTINLL software (Sreerama et al., 1999; Whitmore and
Wallace, 2004; Lees et al., 2006). In our case the CD spec-
tra of 29–48 proteins were used for calculation of the sec-
ondary structural elements.
RESULTS
Amino acid analysis of COOH-modified (etoxyglycylated)
GTH showed that eight free accessible carboxyl groups lo-
cated on the surface of the subunit were modified and con-
verted to neutral ones. Also, it was found by additional
amino acid analysis that the number of modified COOH
groups in GTH did not increase after 20 minutes of inter-
action with the modifying reagent. The modification (neu-
tralisation) of GTH (GTHmod) significantly decreased its
electrophoretic mobility(Rf ) 0.03–0.12, in comparison with
that of standard intact GTHst (0.41–0.58) (Fig. 1).
Comparison of the immunoreactivity of GTHmod and
GTHst in double immunodiffusion tests using GTHst an-
tiserum (stepwise two-fold dilutions of the tested antigens)
showed that GTHmod did not interact with the antibodies
raised against standard subunit GTHst.
GTHst was recombined with intact GTH to produce
dimer GTHst + GTHmod by self-reassociation of both
counterpart subunits. This approach was used to elucidate
the possible structure-functional impact caused by neutrali-
sation of the negative molecular charge of the subunit on
Fig. 1. Analytical PAGE at
pH 8.9, Tris-glycine buffer,
pH 8.3. 100 ìg of each
preparation was applied to
the gel, employing 360 V
and 85 mA: (1) âGTHst; (2)
âGTHmod; (3) áGTHst +
âGTH s t ; (4) áGTH s t+
âGTHmod.1 2 3 4
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both the specific hormonal function and immunoreactivity
of the dimer struture GTHst + GTHmod, in comparison
with that of the control dimer GTHst + GTHst (Table 1).
As seen, by the biological properties of the recombined
dimers in the comparative double immunodiffusion test
with the standard GTH antiserum (Table 1), the substitution
of the native GTH in the – dimer by the GTHmod low-
ered the dimer immunoreactivity by 25% while the specific
hormonal function lacked completely.
Comparative PAGE of GTHst + GTHst and GTHst +
GTHmod indicated that Rf of GTHst + GTHmod consid-
erably decreased toward the anode (Rf 0.02–0.13) in com-
parison with that of the standard subunit dimer GTHst +
GTHst (0.14–0.28) (Fig. 1). Each of the compared reasso-
ciated dimers formed a massive and compact electropho-
retic band. Also, Rf of GTHmod (0.03–0.11) decreased
sharply in comparison with that of GTHst (0.41–0.58)
(Fig. 1).
CD spectra (Fig. 2) indicate that the conformation of
GTHst and GTHmod is characterised by a negative band
around 193–197 nm and a shoulder (or two minor negative
bands) at 205 and 215 nm that is weakly expressed. The
negative Cotton effect around 195 nm is close to the well
known negative band of the random coil at 198 nm, while
the shoulder and the negative band (around 205 and 215
nm) might be due to the contribution of the -structures in-
fluenced by minor content of the -helix (Lees et al., 2006).
The results of the calculations and the shape of measured
CD spectra indicated that there were no considerable dis-
tinctions between the content of various secondary structure
elements of GTHmod and GTHst (Table 2).
DISCUSSION
Electrophoresis of GTHmod showed that etoxyglycylation
of eight free accassible COOH groups resulted in a sharply
declined negative charge of the modified subunit. PAGE
indicated that Rf of the GTHmod (0.03–0.12), unlike the 
GTHst (0.41–0.58), was very close to that of the positively
charged  GTHst. (0.05–0.15) (Zenkevics et al., 2003).
Immunodiffusion tests with the GTHst antiserum showed
T a b l e 1
BIOLOGICAL PROPERTIES OF REASSOCIATED – DIMERS





GTHst + GTHst GTH 100 100
GTHst + GTHmod GTH 75 0
st – standard; mod. – modified COOH-groups
Fig. 2. CD spectra of sturgeon GTH st ( ), mod (– – –).
T a b l e 2
CONTENT OF SECONDARY STRUCTURAL ELEMENTS (%) OF
STANDARD AND COOH-MODIFIED -SUBUNITS
Preparation * * t* R*
GTHst 1.9 24.7 15.2 58.2
GTHmod 2.3 24.2 14.3 59.2
*, -helix; , -strand; t, -turn; R – random coil; st, standard; mod,
modified COOH-groups.
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that GTHmod was completely inactive. In other words, an-
tibodies specific for  GTHst cannot recognise GTHmod.
This quite clearly shows that the neutralisation of carboxyl
groups may play a considerable role in sustaining the struc-
ture of the antigenic determinant groups of the subunit re-
sponsible for the stereospecific interaction with the active
sites of the GTHst-specific antibodies. Also, it must be
taken in consideration that the neutralisation of eight COOH
groups located on the surface of the subunit may also pro-
duce a considerable redistribution of the surface charge of
the modified subunit, which may cause an indirect impact
on the thre-dimensional spatial structure and cause some de-
terioration in the site (determinants) configuration responsi-
ble for the immunospecificity of the subunit. This may ac-
count for lack of the specific immunoreactivity of the
GTHmod typical of the GTHst.
CD-spectroscopy studies showed that the removal of the
negative charges of GTHst did not produce any consider-
able shifts or appreciable distortion in spatial structure of
the modified subunit, in comparison with that of the intact
standard subunit (Fig. 2, Table 2). In order to determine
whether GTHmod can interact with its counterpart GTHst
to form stable – dimer structure typical of GTH, both
counterpart subunits were submitted to self-reassociation.
Investigation of the obtained dimer GTHst + GTHmod in
PAGE tests showed quite clearly that the modified dimer
was stable (Fig. 1). This also indicated that GTHmod on the
whole retained its native configuration and complementarity
of the sites responsible for subunit-subunit interaction
(reassociation), structural stability of the – heterodimer
and stereospecificity of its active sites responsible for the
specific interaction with the native counterpart GTH.
Based on this finding, it is apparent that modified COOH
groups of GTH are not directly involved in the subunit–
subunit interactions and in the formation of the three-di-
mensional functionally active structure recogniseable by ac-
tive sites of standard GTH antibodies. However, even mini-
mal distortions of the three-dimensional structure of
stereocomplementary interacting protein structures may
produce certain shifts in their specific biological function.
Immunoreactivity tests with standard GTH antiserum in
double diffusion reactions showed that immunoreactivity of
the hybrid molecule GTHst + GTHmod decreased at least
by 25% in comparison with that of the control GTHst +
GTHst (Table 1). Immunoidentity tests using standard
GTH antiserum indicated partial identity (spur) between
these two preparations. This means that the complementary
interaction of the GTHmod with the GTHst produced a
certain incompatibility of the antigenic determinant groups
in obtained hybrid dimer – structure, in comparison with
that of the standard dimer.
The present results show that the neutralised eight nega-
tively charged free carboxyl radicals were not critical for
the stability of the native three-dimensional spatial structure
of the subunit necessary for the recognition of the spe-
cies-stereospecific interaction sites of the standard GTH to
form stable dimer structure typical for the hormone. On the
other hand, comparison of the immunoreactivity of GTHst
and GTHmod using GTHst antiserum indicated that the
modified GTH was inactive. This showed quite clearly
that the free COOH radicals are critical for the immunologic
activity of the GTH. Based on this finding, it is apparent
that COOH radicals may be inferred to be essential structure
elements of the antigenic determinant groups of the GTH.
The comparative evaluation of hormonal activity showed
(Table 1) that the modified recombinant GTHst +
GTHmod was completely inactive.
This indicates that eight free COOH groups, located on the
surface of the subunit, have direct importance for the spe-
cific hormonal function and are much less critical for the
immunologic function of the dimer structure of the hor-
mone.
The ability of the standard GTH antiserum to interact with
the recombinant GTHst + GTHmod in the immuno-
specific double diffusion tests indicated that the modifica-
tion of the eight COOH groups of the GTH did not prevent
the formation of the – dimer structure typical of the hor-
mone and are recognisable by the active sites of standard
GTH antibodies.
However, these data allow to conclude that the modified
COOH groups are not directly involved in the subunit-
subunit interactions and in the formation of functionaly ac-
tive three-dimensional structure of the recombinant.
The conformation of the investigated recombinant GTHst
+ GTHmod, comprising GTHmod, is quite closely re-
lated to that of the standard GTH, as indicated by anti-
gen–antibody immunospecific interaction that necessitates
quite close stereospecific fit between the antigenic determi-
nant groups of the modified antigen GTHst + GTHmod
and the standard GTH in immunorection with active sites of
the standard GTH antibodies.
Regarding hormonal activity, even minimal distortions of
the three-dimensional structure of protein-like bioregulators
may alter their functional (effector) group disposition on the
molecular surface, causing considerable shifts in their abil-
ity to interact with the hormone-specific receptor sites of the
cell membrane to induce the hormonal effects. The results
also support our previous findings that the immunological
properties of sturgeon GTH are much less vulnerable than
its specific hormonal function (Çåíêåâè÷ è äð., 1992;
Çåíêåâè÷, 1992).
Based on these findings it can be concluded that the eight
free COOH groups located on the surface of GTH are
main structural components of the species-specific antigenic
determinant groups of the subunit, but are not directly in-
volved in both maintaining the conformation of the subunit
and in its ability to interact with the native counterpart sub-
unit. COOH groups of GTH, as bearers of the main nega-
tive charge potential located on the surface of the hormone
molecule, play a decisive role in the specific hormonal ac-
254 Proc. Latvian Acad. Sci., Section B, Vol. 66 (2012), No. 6.
tivity of GTH at the hormone-competent cell level. The ob-
tained results showed that free COOH groups are directly
involved in the formation of the effector zones (active sites)
of GTH dimer molecule responsible for the stereospecific
interaction with the test-oocyte membrane hormone-sensi-
tive binding (receptor) sites to induce the gonadotropic ef-
fects. Based on these findings, it is apparent that the pro-
nounced negative molecular charge and the conformational
rigidity of the βGTH may serve as a molecular core impart-
ing the molecular charge disposition and species specific
features of the three-dimensional spatial structure of the
αGTH essential for the gonadotropic function of the hor-
mone molecule.
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STORES GONADOTROPÎNA IZTEIKTI NEGATÎVI LÂDÇTÂS β SUBVIENÎBAS ÎPAÐÂ STRUKTÛRFUNKCIONÂLÂ LOMA
Stores β subvienîbai (βGTH), atðíirîbâ no αGTH, ir raksturîgs izteikti negatîvs molekulârais lâdiòð. Selektîvâs íîmiskâs modifikâcijas ceïâ
βGTH izdevâs neitralizçt visas astoòas brîvâs COOH grupas. Modificçtâ subvienîba pilnîbâ zaudçja spçju mijiedarboties ar standart-
subvienîbas antivielâm. Krasi samazinâjâs tâs elektroforçtiskâ virzîba uz anodu. Taèu CD spektroskopijas pçtîjumi liecinâja, ka
modifikâcija nav radîjusi bûtiskas izmaiòas βGTH otrçjâ struktûrâ. Modificçtâ βGTH spçja reasociçties ar natîvo αGTH, veidojot
elektroforçtiski stabilu α–β dimçru, kura imûnreaktivitâte salîdzinâjumâ ar intakto subvienîbu α–β dimçru izrâdîjâs par 30% zemâka
imûntestos ar GTH antivielâm. Taèu tâs hormonaktivitâte bija pilnîbâ zudusi. Secinâts, ka brîvâm COOH grupâm ir bûtiska nozîme βGTH
antigçno determinantu struktûras veidoðanâ, bet to loma subvienîbu specifiskâs komplementârâs mijiedarbîbas procesâ nav îpaði nozîmîga.
Pçtîjuma rezultâti râda, ka brîvajâm COOH grupâm ir îpaða nozîme hormona dimçrmolekulas efektorajâs zonâs jeb aktîvajos centros, kas
nodroðina GTH molekulas stereospecifisko mijiedarbîbu ar olðûnu membrânreceptoriem, tâdçjâdi inducçjot gonadotropâ procesa norisi
olðûnâs.
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INTRODUCTION
Ascorbic acid (AA) has antioxidant effects and can protect
tissue against damage caused by strong oxidants that con-
tain reactive oxygen species. AA forms a redox system and
is also connected with the glutathione (GSH) system (Win-
kler et al., 1994; Kohen and Nyska, 2002). Oxidative stress
decreases AA concentration in tissues, and therefore, sup-
plementation of AA is required in diet. However, AA may
alter the pro-oxidant-antioxidant balance in poultry, depend-
ing on its dose and the concentrations of redox-active transi-
tion metal ions (iron, cadmium, copper, lead, mercury and
chromium) in tissue (Poljsak et al., 2005). Increased oxida-
tive stress has been implicated in heavy metal overload con-
ditions. For example, cadmium induces a significant in-
crease in reactive oxygen species (Gobe and Crane, 2010).
Cadmium is a toxic metal and targets the liver and kidneys
following acute and chronic intoxication, which may induce
cell death via apoptosis. Dietary supplementation with anti-
oxidants is an important consideration for limiting renal
oxidative stress and progression of chronic kidney disease
(Brown, 2008). After necrotic cell death, a burst of uric acid
is released from the cells, which induces acute inflamma-
tory responses (Kono et al., 2010).
Inflammation is triggered by circulating immune complexes
(CIC) that enter the tissue (Clynes et al., 1999). Uric acid is
normally excreted from the body via the kidneys (80%) and
intestines (20%). Heavy metal poisoning increases the con-
centration of uric acid in human serum, whereas therapeutic
dosages of AA facilitate the excretion of uric acid (Mitch et
al., 1981). The concentration of serum creatinine can also
be used to estimate renal dysfunction (Eisner et al., 2010).
Only scanty and contradictory information is available con-
cerning the oxidative stress response of metabolic organs to
a range of doses of ascorbic acid (Duarte and Lunec, 2005;
Poljsak et al., 2005).
The aim of the present study was to determine the effect of
dietary supplementation of ascorbic acid, using a wide
range of doses, on the content of a heavy metal, such as
cadmium, in the liver and kidney, and on the oxidative
status, innate immunity and kidney function markers in
chicks.
MATERIALS AND METHODS
Animals. New-hatched Lohmann brown cockerels were ob-
tained from the Latvian poultry company BALTICOVO.
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The effects of ascorbic acid supplementation on biomarkers of oxidative stress, cadmium accu-
mulation in organs, immune system activity and kidney function in chickens were investigated.
The treatment groups of chickens were fed either plain diet or diet supplemented with ascorbic
acid at 100, 500, 1000 and 2000 mg/kg for four weeks. Liver and kidney tissues were assayed for
cadmium concentration, and the hepatic levels of ascorbic acid and dehydroascorbic acid (DHAA;
the oxidised form), malondialdehyde, glutathione, activity of glutathione peroxidase, blood serum
uric acid, creatinine, lysozyme and circulating immune complexes were measured. Supplementa-
tion with a high dose of ascorbic acid (1000 and 2000 mg/kg in the diet) caused an imbalance be-
tween pro-oxidative and antioxidative activities, and induced a suppressive effect on innate
immunity. The results suggest that oxidative stress compromises renal function. We observed
that ascorbic acid increased cadmium accumulation in a dose-dependent manner.
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Experimental design. All of the experimental procedures
were approved by the Animal Ethics Committee of the
Food and Veterinary Service (Riga, Latvia, authorisation
reference number 13, from 22 December 2008). The chick-
ens were housed in cage units with free access to food and
water. The experiment was conducted using one- to thirty-
day-old chickens.
The animals were divided into five groups of 25 animals
each. Control group chickens (Control) received a basal
wheat-barley diet containing all of the necessary nutrients
without any ascorbic acid supplementation. The chickens of
the other four groups were provided with the same basal
diet that was supplemented with one of the following doses
of ascorbic acid, AA (Sigma-Aldrich, St. Louis, Missouri,
USA): 100 mg/kg (100 AA, second group), 500 mg/kg (500
AA, third group), 1000 mg/kg (1000 AA, fourth group), and
2000 mg/kg (2000 AA, fifth group).
Physiological and biochemical study. At the end of the ex-
periment, the cockerels were sacrificed by decapitation in
accordance with the recommendation for the euthanasia of
experimental animals of the European Convention (Close et
al., 1997). Peripheral blood samples, liver and kidney were
collected for analysis.
Lipid peroxidation in chicken tissues was determined by
thiobarbituric reaction. The results were expressed as µmol
malondialdehyde (MDA) per gram of fresh tissue (Surai et
al., 1996). The total vitamin C, and dehydroascorbic acid
(DHAA) concentrations in chick liver were estimated by the
2.4-dinitrophenylhydrazine colorimetric method; the re-
duced ascorbic acid (AA) content was calculated by sub-
traction (Surai et al., 1999). The glutathione level in the
liver was measured spectrophotometrically using 5.5-ditio-
bis-para-nitro-benzoic acid (Beutler et al., 1963). The activ-
ity of glutathione peroxidase (GSH-Px, EC 1.11.1.9) in liver
was assayed by the coupled enzyme procedure using hydro-
gen peroxide as the substrate (Pinto and Bartley, 1969). The
concentration of cadmium in chicken liver and kidney were
determined using atomic absorption spectrophotometry
(Anonymous, 2000). Uric acid concentration in blood serum
was estimated by the carbonate method using colorimetric
procedure (Eichhorn et al., 1961). The creatinine content in
blood serum was measured using the colorimetric method
with alkaline picrate, based on the Jaff reaction (commercial
biochemical kit, Divi-Dent). The indices of non-specific
humoral immune responses were examined in chickens im-
munized intraperitoneally with 0.1 ml 10% sheep red blood
cells in PBS seven days before the end of experiment. Se-
rum lysozyme level was estimated using a mo dified
bacteriolytic method (Ãðàíò è äð., 1973) based on
absorptiometric determination of the decrease in turbidity of
a suspension of Micrococcus lysodeikticus, as described by
Shugar (1952). Nonspecific circulating immune complexes
in serum were estimated spectrophotometrically after pre-
cipitation with polyethyleneglycol 6000 (Riha, 1979).
Statistical analysis. The data were expressed as the means
± SD. The differences between the control and four experi-
mental groups were analysed using analysis of variance
(ANOVA) followed by the Dunnett’s test and Tukey’s post
hoc test. A P value of 0.05 was considered statistically sig-
nificant.
RESULTS
The level of reduced AA and DHAA in chick liver (Fig. 1)
depends on the AA dose in diet. The reduced AA content
relative to the DHAA content decreased more than two
times in chickens receiving high doses of AA (1000 and
2000 mg/kg of diet). Tables 1 and 2 show that the ascorbic
acid concentration in the diet is correlated with the accumu-
lation of cadmium in liver and kidney. The concentration of
cadmium in the liver increased when ascorbic acid was sup-
plemented in the diet at doses of 500 (P < 0.0002), 1000
(P < 0.0001) and 2000 mg/kg (P < 0.0001). The content of
this heavy metal in kidney significantly increased when
ascorbic acid was added to the diet at a dose of 2000 mg/kg
(P < 0.02). Moreover, the ascorbic acid at doses of 500
mg/kg, and particularly at 1000 and 2000 mg/kg, signifi-
cantly decreased the level of GSH. However, ascorbic acid
decreased the activity of GSH-Px at doses of 1000 and 2000







AA 1.84 2.5 1.51 0.96 0.91
DHAA 1 1 1 1 1
Control 100 AA 500 AA 1000 AA 2000 AA
Fig. 1. Proportion of dehydroascorbic acid and re-
duced ascorbic acid to total vitamin C in liver of
chickens receiving diet with different ascorbic acid
levels from hatching to 30 days of age
mg/kg. Increased MDA formation in the liver was detected
with ascorbic acid doses of 1000 and 2000 mg/kg.
Animals that were fed a diet that was supplemented with
ascorbic acid at doses of 1000 and 2000 mg/kg had a higher
concentration of uric acid in blood serum (Table 2). In addi-
tion, chickens that received ascorbic acid at doses 1000 and
2000 mg/kg displayed increased serum levels of creatinine
compared to the control group (Table 2).
Parameters of innate humoral immunity in the treated chick-
ens are shown in Table 2. Lysozyme activity in blood serum
of chickens that were fed diets enriched with ascorbic acid
at all doses was significantly decreased compared to that in
the control group. The serum CIC level was decreased in
chickens that were fed diets containing ascorbic acid at
doses of 500, 1000 and 2000 mg/kg compared to that in the
control group. Dose-dependent effects on lysozyme activity
and CIC level were observed.
DISCUSSION
The focus of the present study was to provide a better un-
derstanding of the effects of dietary ascorbic acid supple-
mentation to chicken. Chicken as an experimental model is
especially useful in biological studies due to its high inten-
sity of some metabolic processes (Klandorf et al., 1999).
Birds differ from primates and guinea pigs by their capacity
to synthesise ascorbic acid endogenously. However, a die-
tary supplementation of ascorbic acid can be beneficial for
poultry to improve performance and egg production.
Ascorbic acid can act as an antioxidant, contributing to the
total antioxidant capacity of an animal’s antioxidant defence
system. Intake of ascorbic acid in a low dose (100 mg/kg
diet) in our experiment indicated some increase of antioxi-
dant activity in chicken organs. Our study demonstrated that
hepatic GSH levels and GSH-Px activity were decreased in
chickens that received 500, 1000 and 2000 mg/kg of ascor-
bic acid compared to those in the control group. The con-
current significant increase of MDA levels in chickens in
the 1000 and 2000 mg/kg AA groups indicated an imbal-
ance between anti-oxidative and pro-oxidative responses in
liver. Elevated levels of MDA, which is an end product of
polyunsaturated fatty acid oxidation, suggested that ascorbic
acid at a dose of 1000 and 2000 mg/kg in the diet exhibited
pro-oxidative effects.
The fraction of the dehydroascorbic acid of total vitamin C
might provide useful information about the level of oxida-
tive stress. Consequently, the ratio of DHAA to total
ascorbate could be a marker of oxidative stress (Lykkesfeldt
et al., 1997). The reduction of DHAA to AA occurs
intracellularly and depends on both ascorbic acid and the
dominant intracellular reductant glutathione. In the present
study, we found AA overload to be a predictor of high liver
concentrations of the oxidised form of ascorbic acid,
DHAA.
We demonstrated that ascorbic acid stimulated cadmium ac-
cumulation in organs in a dose-dependent manner. This may
be due to stimulation of the intestinal absorption of cad-
mium by ascorbic acid. The uptake of cadmium into
enterocytes is mediated by the divalent metal transporter 1
(DMT1), which is a proton-coupled transporter (Park et al.,
2002). The capacity of DMT1 transport is optimal at pH 5.5
(Gunshin et al., 1997). Therefore, the absorption of cad-
mium was possibly increased by ascorbic acid via a de-
creased luminal pH.
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T a b l e 1
HEPATIC CADMIUM CONCENTRATION, GLUTATHIONE LEVEL,
GLUTATHIONE PEROXIDASE ACTIVITY AND MALON-
DIALDEHYDE FORMATION IN CHICKENS THAT RECEIVED DI-










1. Control 0.22 ± 0.02 4.83 ± 0.27 4.46 ± 0.46 29.56 ± 1.68
2. 100 AA 0.26 ± 0.04 4.92 ± 0.36 4.49 ± 0.54 32.05 ± 1.42
3. 500 AA 0.38 ± 0.06* 4.17 ± 0.18*** 4.37 ± 0.27 31.51 ± 3.45
4. 1000 AA 0.40 ± 0.05** 3.91 ± 0.23** 3.30 ± 0.15** 34.68 ± 1.47*
5. 2000 AA 0.46 ± 0.03** 3.75 ± 0.31 ** 3.20 ± 0.11** 42.17 ± 3.73**
Cd, cadmium; AA, ascorbic acid; GSH, glutathione; GSH-Px, glutathione
peroxidase and MDA, malondialdehyde. Statistically significant differ-
ences from the control group: *P = 0.0002; **P < 0.0001 and ***P =
0.0006.
T a b l e 2
CONCENTRATION OF CADMIUM AND PARAMETERS OF RENAL
FUNCTION IN CHICKENS THAT RECEIVED DIET SUPPLE-
MENTED WITH ASCORBIC ACID (MEAN ± SD)






1. Control 1 0.20 ± 0.00 131.59 ± 18.33 67.40 ± 2.31
2. 100 AA 0.20 ± 0.00 116.59 ± 5.82 57.12 ± 0.29***
3. 500 AA 0.26 ± 0.02 117.42 ± 12.49 60.73 ± 0.25***
4. 1000 AA 0.30 ± 0.04 167.38 ± 27.48* 119.51 ± 6.54***
5. 2000 AA 0.32* ± 0.03 175.71 ± 14.15** 126.59 ± 3.31***
Statistically significant differences from the control group: *P = 0.02;
**P = 0.0008 and ***P < 0.0001.
T a b l e 3
PARAMETERS OF INNATE HUMORAL IMMUNITY IN CHICKENS
THAT RECEIVED DIET SUPPLEMENTED WITH ASCORBIC ACID
(mean ± SD)
Group Lysozyme activity in blood
serum, μg/ml
Circulating immune com-
plexes (CIC) in blood serum,
extinction units ± 100
1. Control 10.75 ± 0.20 4.13 ± 0.44
2. 100 AA 6.36 ± 0.54* 4.20 ± 0.89
3. 500 AA 3.12 ± 0.19* 2.43 ± 0.35*
4. 1000 AA 2.88 ± 0.10* 3.07 ± 0.71**
5. 2000 AA 1.85 ± 0.10* 1.47 ± 0.19*
Statistically significant differences from the control 1 group: *P < 0.0001
and **P = 0.01.
This study indicated a close relationship between serum
lysozyme and CIC levels, which are inflammatory markers,
in chickens that were fed diets that were supplemented with
500, 1000 and 2000 mg/kg AA. The bulk of CIC most
likely contains antibodies against autoantigenic proteins,
microbes and nuclear antigens, whereas lysozymes in serum
predominately originate from macrophages (Torsteinsdottir
et al., 1999; Wiik, 2003). Proteins that are modified by re-
active oxygen species have been shown to elicit antibodies
in a variety of diseases (Kurien and Scofield, 2008). The
significant reduction of serum lysozyme and CIC levels in
chickens that received 2000 mg/kg AA in the diet suggested
that immune system function was suppressed, which may
be associated with oxidative damage of macrophages and
plasma cells.
Our study demonstrated that a high dose of ascorbic acid in-
take caused elevated levels of serum uric acid and
creatinine. The antioxidant activity of ascorbic acid at low
doses may improve kidney function by protecting renal tu-
bular uric acid and creatinine secretory transporters from
oxidative injury. Excessive ascorbic acid intake likely had
an adverse effect on renal function, leading to reduced tubu-
lar excretion through the dysregulation of renal tubular uric
acid and creatinine secretory transporters via ROS.
Uric acid is a powerful antioxidant (Waring, 2002). The ob-
served high serum uric acid levels in chickens in the 1000
and 2000 mg/kg AA groups suggests that these chickens
cannot manage ROS effectively and that transient impair-
ment of renal functions may occur.
In summary, the results of our study demonstrated that high
doses of ascorbic acid in the diet exhibited a pro-oxidative
effect. The “threshold” concentration of ascorbic acid for
this effect was 1000 mg/kg in the chicken diet. Furthermore,
consistent exposure to high doses of dietary ascorbic acid
(1000 and 2000 mg/kg) induces loss of normal antioxidant
reserves and immunosuppression, rendering the animals
more susceptible to renal disturbances. In addition, a
stimulatory effect of ascorbic acid on cadmium accumula-
tion in organs and pro/anti-inflammatory activities was
demonstrated.
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ASKORBÎNSKÂBES ANTIOKSIDATÎVÂ/PROOKSIDATÎVÂ AKTIVITÂTE ATKARÎBÂ NO KONCENTRÂCIJAS CÂÏU
ORGANISMÂ
C vitamîns piedalâs daudzos vielmaiòas procesos. Tas stiprina organisma imûnsistçmu, piedalâs bioloìiskâs oksidçðanâs un reducçðanâs
procesos. Askorbînskâbe un dehidroaskorbînskâbe veido redoks sistçmu un ir saistîtas ar glutationa sistçmu. Daþâdu stresu ietekmç
askorbînskâbes koncentrâcija audos samazinâs. Tâdçï barîbu vajag bagâtinât ar ðo vitamînu. Darba mçríis bija pçtît daþâdus oksidatîvâ
stresa biomaríierus câïu organismâ, kadmija akumulâciju orgânos, imûnsistçmas aktivitâti un nieru funkcijas izmaiòas askorbînskâbes
ietekmç atkarîbâ no tâs koncentrâcijas barîbâ. Eksperimentos izmantojâm vienu dienu vecus Lohmann Brown gailîðus, kurus sadalîjâm
piecâs analogâs grupâs. Câïi saòçma kombinçto barîbu bez vai ar askorbînskâbes piedevâm (0, 100, 500, 1000 un 2000 mg/kg) èetru nedçïu
laikâ. Konstatçjâm, ka askorbînskâbe nelielâ koncentrâcijâ (100 mg/kg barîbas) câïu organismâ darbojas kâ antioksidants. Pçtîjumâ
pierâdîts, ka, palielinot ðî vitamîna daudzumu barîbâ (1000 un 2000 mg/kg), dzîvnieku organismâ mainâs antioksidatîvo – prooksidativo
procesu lîdzsvars, un tâ rezultâtâ attîstâs oksidatîvais stress: aknâs palielinâs C vitamîna oksidçtâs formas — dehidroaskorbinskâbes
daudzums, samazinâs glutationa lîmenis un glutationperoksidâzes aktivitâte, uzkrâjas nepiesâtinâto taukskâbju oksidçðanas gala produkts
malondialdehîds, inducçjâs nespecifiskâs imunitâtes supresija, traucçtas nieru funkcijas. Novçrojâm, ka askorbînskâbe, atkarîbâ no
koncentrâcijas, veicina smago metâlu, t.sk. kadmija akumulâciju câïu aknâs un nierçs.
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INTRODUCTION
The territory of Latvia is rich in lakes. There are 2256 lakes
with a surface area larger than 1 ha. The majority of lakes in
Latvia are small. Only 16 lakes have an area larger than
1000 ha or 10 square kilometres (Tidriíis, 1995). Still, they
account for 40% of the total area of the lakes. Most lakes
are located in highlands (approximately 40% of the lakes
occur in the highlands of Latgale and Augðzeme). The low-
est number of lakes occur in Zemgale where the low plain
and numerous rivers do not allow accumulation of water.
The total area of lakes in Latvia is about 1000 square kilo-
metres. This area amounts to about 1.5% of the area of Lat-
via, and the proportion is similar to that in Lithuania but
considerably less than in Estonia (5%), Sweden (8.5%) or
Finland (9%). In Latvia there are many lakes, as glaciers
covered this territory in not so far distant past. The ice-
cover and water resulting from its melting caused formation
of a terrain rich in hilly and depressions, which facilitated
flow of water from raised parts and its accumulation in
lower areas. Lakes formed by pools in marshes and bogs are
not recorded in Latvia, but their number could be above ten
thousand. In the 20th century, the number of lakes decreased
due to overgrowing, drainage projects and merging of lakes.
Lakes are one of the most common landscape elements in
Latvia and in the Baltic region, which includes also some
highlands with lakes in Lithuania, Poland and Northern
Germany. Lakes are a natural indicator that reflects the wa-
ter regime of the region and its variability. The dynamics of
the condition of a lakes over time is best characterised by
the water level regime and its changes brought about by
natural and anthropogenic factors. Similar to fluctuation of
the volume of discharge of waters, cyclic and periodic
changes over the span of centuries are characteristic also for
fluctuation lake levels. These cyclic fluctuations are caused
by various macroprocesses, such as atmospheric circulation,
changes in the solar radiation which determines the thermal
and ice regime of the lakes, and the amount of precipitation
(Glazaèeva, 1975).
The history of the modification of the hydrological regime
of lakes by human activity in Latvia started already in the
18th–19th centuries. The largest changes occurred in the 20th
century, with increased alteration made by land drainage,
hydro-energy projects, fisheries and other management
types that affected the level of lakes.
Wide research on the hydrological regime of Latvian lakes
and its changes were carried out in the 1930s, for example,
investigations on large lakes near Rîga by Stakle (1935) and
on morphometric elements and regimes by Slaucîtâjs
(1935; 1937; 1938). In the 1950s to 1970s, studies were car-
ried out on the morphometry of the Latvian lakes, etc.
(Êîòîâ è äð., 1958) and on the thermal and ice regime of
rivers and lakes by Glazacheva (Ãëàçà÷åâà, 1964; 1965;
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Changes in the hydrological regime of the lakes of Latvia have been caused by several natural
and human factors. This publication summarises the results of research on the long-term and
seasonal changes in the water level, and thermal and ice regimes of the three biggest lakes of
Latvia (Usma, Burtnieks, and Râzna) and their regional features in the period from 1926 to 2002.
The levels of the lakes Usma and Râzna have been controlled, but it can be considered that
changes of the water level in Lake Burtnieks have been due to the impact of natural factors dur-
ing the period from 1947 to 2002. Global climate warming has caused considerable changes in
the hydrological regime of the lakes during the last decades, as the water level and temperature
have increased and the number of days with ice cover and the thickness of ice have decreased.
A positive trend in the freezing data and statistically reliable negative trend for the ice break-up
date were observed for all the lakes. Lake Usma is located in the western part of Latvia, there-
fore, its hydrological regime, in particular, the thermal and ice regime, differs from those of lakes
Burtnieks and Râzna which are located in the northern and eastern part of Latvia, respectively.
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Glazaèeva, 1975). The publications by Tidriíis (1995) and
Glazaèeva (2004) are among the last reviews on the hydro-
logical regime of Latvian lakes and its changes. It should be
noted that lately no broad research on this topic has been
carried out, and generally, since 2003–2004, regular moni-
toring of Latvian lakes is no longer performed.
The objective of this study was to analyse long-term
changes of hydrological regime, i.e. water level and tem-
perature, ice occurrence, and regional features of the three
largest Latvian lakes: Usma, Burtnieks, and Râzna.
MATERIALS AND METHODS
Studied lakes. The three biggest lakes of Latvia (Usma,
Burtnieks and Râzna) that had long series of observation
data and different physical geographic location (Fig. 1)
were selected for the study. The main characteristics of the
lakes are presented in Table 1.
Lake Usma (57°12'N 22°10'A) is located in the western part
of Latvia at 20.6 m a.s.l. (Eipurs, 1998) in the Ugâle plain
of the Kursa lowland, in the Irbe river basin. The surface
area of the lake is 37.2 km2. Usma Lake is a remnant of the
Baltic Ice Lake. The lake bed stretches from the North to
South with length 13.5 km; the widest part (6 km) is in the
middle part of the lake. Usma Lake is the second biggest
lake in Latvia from the point of view of the water volume
(190 mill. m3) and the estimated water turnover is two
years. It discharges to the Baltic Sea at its north-western end
via the Engure River — Puzes Lake — and then Rinda and
Irbe Rivers. In comparison to the other studied lakes, Lake
Usma has a high average and maximum depth (5.4 m and
27 m, accordingly).
Burtnieks Lake (57°44’ N 25°14’ A) is the fourth biggest
lake in Latvia. It is located at 39.5 m a.s.l. in the northern
part of Latvia in the Tâlava lowland (Tidriíis, 1994). The
water surface area is 40.06 km2. The lake bed is of glacial
origin and stretches in the direction from the North West to
the South East. Its length is 13.3 km, and maximum width is
5.5 km. Lake Burtnieks is a shallow lake with average depth
2.2 m and maximum depth 3.3 m. This lake represents a
flow lake, as water turnover takes place on average six to
seven times per year (in spring once every 2–3 weeks and in
summer once in three months). It discharges to the Riga
Gulf via the Salaca River at the north-western end of the
lake where the width at the discharge is 25–30 m. Lake
Burtnieks has the biggest basin (2215 km2), which exceeds
its water surface area (40.06 km2) by 55 times. This factor
causes large seasonal fluctuation of the water level.
Lake Râzna (56°19’ N 27°27’ A) is located in the South
East part of Latvia on the highest part (163.4 m a.s.l) of the
Latgale highland in the Râznava hilly section (Lumane,
1997). This is the second biggest lake of Latvia from the as-
pect of the water surface area. Its area is 57.6 km2, and in
1956–1974, following the lowering of the level of Lubâna
Lake, it became the biggest lake in Latvia. In terms of the
water volume, Lake Râzna is the biggest lake in Latvia.
The total volume is 405 mill. m3 or 1/5 of the aggregate
volume of all lakes of Latvia. The lake bed is of glacial ori-
gin, rounded with a slight straighter stretch from the East to
the West. Its length is 12.1 km and the largest width is 6.9
km in the east part of the lake. The average depth is 7 m and
maximum depth is 17 m. Lake Râzna is a flow lake, and av-
erage discharge is 240 mm. The discharge of the lake occurs
in the western part via the Rçzekne River — Lake Kaunata.
If the water level is high, discharge occurs also in the
north-western part of the lake via Lake Zosnas and Kazupe
River to the Malta River.
Data and methods. In the analysis of the hydrological re-
gime of the studied lakes the hydrological monitoring data
T a b l e 1












Usma 396 37.2 190 27 5.4
Burtnieks 2215 40.1 88 3.3 2.4
Râzna 221 57.6 405 17.0 7.1
Fig. 1. Location of the studied lakes.
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from the funds of the Latvian Environment, Geology and
Meteorology Centre (Anonymous, 2011) and the publica-
tion of the Marine Board by Stakle and Kanaviòð (1941)
were used. For the purpose of analysis of the water levels,
the monthly mean data in centimetres above the zero post
mark have been used and the observation periods for the
studied lakes differ in this case (Table 2). Systematic moni-
toring of the water level of Lake Usma was started in Sep-
tember 1926 at Usmaciema hydrological station that was es-
tablished by the Latvian Sea Department. The gauging
station „Usma” is located 4 km to the North East of the
mouth of the Engure River (Fig. 1). Its location and the zero
mark of the post at 20.38 m a.s.l. have remained unchanged
during the period of study. In the analysis of the water level
of Lake Burtnieks the observations from the gauging station
„Burtnieki” at the South East coast of the lake have been
used, the zero mark of the HNS „Burtnieki” is located at
37.84 m a.s.l. In the case of Lake Râzna the gauging station
„Kaunata” is located at the east part of the lake and the
mark of the zero post is at 160.57 m above the sea level.
In the analysis of the long-term trends of the water tempera-
ture the mean monthly data are used: for lakes Usma and
Burtnieks from March to December, and for Lake Râzna
from April to December.
For the analysis of the ice regime the data on the ice thick-
ness and duration days, freezing and break-up dates were
used. The measurements of the thickness of the lake ice
usually are performed from October to April six times per
month, i.e. on the 5th, 10th, 15th, 20th, 25th and the last date
of the month, and as from the winter of 1975/1976 there
have been individual periods or years when the observations
were performed only three times per month. In the study
measurements of the ice thickness in the middle of the lake
are used, and in the case of Lake Burtnieks the missing data
from the winter of 1969–1970 were replaced by inshore ice
thickness observations that are not essentially different from
the measurements of the central part of the lake. After-
wards, the mean and maximum annual ice thickness were
calculated. In the present study, the date of freezing is the
first day of ice occurrence, the date of ice break-up is con-
sidered as the date of disintegration of the ice cover in the
period with regular ice observations, and the number of
days with ice is calculated as the actual number of days on
which ice occurred. For possibly immediate assessment of
the climate changes in the Latvian lakes the severity index
was calculated by Sztobryn et al. (2009). The index was
used for the seasonal number of days with ice and the prob-
ability of ice occurrence.
The multivariate Mann-Kendall test (Lettenmaier, 1988;
Loftis et al., 1991) was used to detect the trend shift in
monthly and annual data analysis. The test was applied sep-
arately to each variable at each site, at a significance level
of P ≤ 0.05. The trend was considered statistically signifi-
cant at the 5% level, if the test statistic was above 1.96 or
below –1.96.
In studies of hydro meteorological time series in the Baltic
Sea area by Kïaviòð et al. (2007) and Stips & Lilover
(2010) the so called breakpoints during the 20th century
were found. One of them refers to year 1987, which could
have determined the long-term changes in hydro-climate
patterns during last decades. Therefore, in our investigation
the entire study period was divided into two periods: until
1987, with “no substantial” climate change impacts, and the
period from 1988, with “substantial” climate change im-
pacts on hydrological processes in Latvian lakes.
RESULTS
Changes in water level. In Latvia the big lakes have been
regulated in recent or not so recent past, therefore, the
long-term changes in their water level depend not only on
the natural factors, mainly climate-related factors, but also
anthropogenic activities. Concerning Lake Burtnieks during
the study period from 1947 to 2002 there are no data about
the works performed by humans in regulating the water
level. Therefore, the long-term changes in the lake level can
be deemed to be natural. This is confirmed by the compari-
son of the long-term changes in the lake level with the cycle
of the changes in the flow of the Salaca River from 1951 to
2002. As it can be seen in Figure 2, two periods can be dis-
tinguished in the water regime of Lake Burtnieks and the
Salaca River: low water from 1947 to 1977 and high water
from 1978 to 2002. The long-term mean water level of the
lake for numerous years was 40.1 m a.s.l., and 39.9 m dur-



































































































































L. Burtnieks R. Salaca




Fig. 2. Annual mean water levels and annual mean flow of the Salaca
River during the period of 1947–2002. The dotted line is the long-term
mean value of water level in the whole period; the interrupted lines are
long-term mean values of water level of the studied periods 1947–1977
and 1978–2002.
T a b l e 2
STUDY PERIODS OF UTILIZED HYDROLOGICAL DATA
Data Lake Usma Lake Burtnieks Lake Râzna
Water level, cm 1926–2002 1947–2002 1948–2002
Water temperature, oC 1946–2002 1946–2002 1948–2002
Ice thickness, cm 1929–1939,
1946–2002
1946–2002 1948–2002
Number of days with ice 1926–2002 1946–2002 1948–2002
Date of freezing 1926–2002 1946–2002 1948–2002
Date of ice break-up 1926–2002 1946–2002 1948–2002
263Proc. Latvian Acad. Sci., Section B, Vol. 66 (2012), No. 6.
period. The long-term seasonal analysis showed that the sta-
tistically reliable positive trend at a significance level of P ≤
0.05 could be observed for the water level of the lake from
January to March and from June to September, but in the
flow of the Salaca this trend could be observed only from
January to March.
Lake Usma is peculiar concerning the fact that the regime
of its water levels has been impacted by direct human activ-
ity. In 1969, on the Engure River not far from its mouth the
eel catching device was constructed (Fig. 3). The water
level in the lake was raised on average by 20 cm. These
changes are also reflected very well in the long-term
changes in the mean water level where during the period
from 1927 to 1968 it was 21 m and from 1969 to 2002 it
was 21.2 m a.s.l. (Fig. 4). Thus, during the study period
from 1927 to 2002, a statistically reliable positive trend
could be seen from January to September, and during the
period from 1927 to 1968, a reliable positive trend could be
identified only in March and April, when the level fluctua-
tions were caused mainly by the natural conditions.
Lake Râzna was regulated for several times (Fig. 5). During
the period from 1951 to 1955, Sprukti hydro power station
(HPS) was built and it was in operation until 1977. During
the period from 1956 to 1962, the flow of the lake was
deepened along the section Lake Râzna — Lake Kaunatas
and on the upper course of the Rçzekne River to direct
higher volumes of water to the Rçzekne River for the opera-
tion of Sprukti HPS. Following the deepening of the out-
flow the level of the lake decreased by 0.3 m. After closing
Sprukti HPS, the natural water level was restored at the lake
for a couple of years from 1985 to 1992 (on average, up to
163.32 m a.s.l.), when the eel catching device was con-
structed and the level was raised by 29 cm. During the pe-
riod from 1993 to 2002, the Kaunata gates and Sprukti HPS
were reconstructed and resumed power generation in 1996.
The gates continue to maintain the level of the lake at the
artificial level which was raised by another 5 cm following
their reconstruction.
Changes in water temperature. The thermal regime of
lakes is determined by the location of the lakes, climatic
conditions, size and depth, inflow of underground and sur-
face waters (streams, rivers). Lakes of the temperate lati-
tude: in summer — direct, in winter — reverse stratifica-
tion. In springs the water warms up slowly, later it
accumulates the warmth, and during other seasons, the wa-
ter is often warmer than the air. The water temperature is
the highest in July and August and the lowest during the pe-
riod of formation of the ice cover. In summer the upper lay-
ers of the deep lakes at the depth of 4–6 m warm up, the
temperature practically does not change at other depth lay-
ers.
The results of the study of the water temperature demon-
strated that the long-term mean temperature was the highest
for Lake Usma where it amounted to 10.3 oC, followed by
Lake Burtnieks with 9.6 oC and Lake Râzna with 9.1 oC
(Fig. 6.). During the time period until 1987, the long-term
mean temperatures in all the lakes were lower than during
the time period from 1988 to 2002, when the climate warm-
ing could be observer. For lakes Usma and Râzna the water
temperature had increased by approximately 1 oC. The
long-term seasonal analysis demonstrated that the statisti-
Fig. 3. The eel catching device on the Engure River not far from its out-






























































































































































































































Fig. 4. Annual mean water levels of Lake Usma during the period of
1927–2002. The dotted line is the long-term mean value of water level of
the whole period; the interrupted lines are long-term mean values of water
level of the studied periods 1927–1968 and 1969–2002.
Fig. 5. Annual mean water level of Lake Râzna during the period of
1949–2002. The dotted line is the long-term mean value of water level of
the period 1949-2002; the interrupted lines are long-term mean values of
water level of the studied periods 1949–1955, 1956–1977, 1978–1984 and
1985–2002.
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cally positive trend could be seen during spring months
March – April, and for Lake Râzna also in July, August,
and December.
Changes in ice freezing and break-up date. The ice for-
mation in the Latvian lakes depends on the length of the pe-
riod between the move of the daily mean temperature below
0 oC and cooling of the water in the lake to 0 oC. Stable ice
cover forms within 2–20 days after the first ice elements
have appeared. At the highlands in the north and east part of
Latvia the ice cover starts to form in the 2nd half of Novem-
ber (Burtnieks — from the 25th November to the 4th
December, Râzna — from the 27th November to the 8th De-
cember), and in the West and middle part of Latvia — in the
1st half of December (Usma — from the 2nd to the 10th De-
cember). It breaks up during the period from the 2nd half of
March to mid-April (Usma: the 31st March – the 13th April,
Burtnieks: the 6th–11th April, Râzna: the 18th–25th April),
and within ten days after that the ice melts at the site. The
climate warming resulted in the ice break-up already in
mid-March or end of March, for example in the case of
Lake Usma the mean date was the 17th March, for
Burtnieks it was the 25th–30th March and for Râzna it was
the 12th April. As it can be seen from Figure 7, the trend




























































































































































































































































































































Fig. 6. Long-term water temperatures in lakes Usma (A), Burtnieks (B) and
Râzna (C). The uninterrupted horizontal line is the long-term mean value of
water temperature of the whole study period; the interrupted lines are
long-term mean values of water temperature of the studied periods








































































































































































































































































































































Fig. 7. Long-term freezing dates and break-up dates for lakes Usma (A),
Burtnieks (B) and Râzna (C). The horizontal lines are long-term mean val-
ues of freezing dates and break-up dates during the whole period.
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can be seen for all the lakes, i.e. there is a positive trend, but
it is not statistically significant. The ice break-up date is ear-
lier, i.e. there is a negative trend and it is statistically signif-
icant at the P ≤ 0.05.
The extreme freezing and break-up dates are summarised in
Table 3. The variation of the dates among the studied lakes
is higher in case of the freezing and lower in case of the ice
break-up. It can be seen very well here that in 1961, 1989,
1990 the earliest break-up dates could be observed in all the
lakes and in 1955, 1956, 1958, 1963 the latest break-up
dates could be observed.
Changes in the numbers of days with ice cover and se-
verity index. Until the year 1998, it could be observed that
on average the ice cover was maintained in the Latvian
lakes for 3.5–5 months or 6 months during severe winters.
As it can be seen in Figure 8, the length of the ice cover var-
ies among the studied lakes. The shortest ice cover length
refers to Lake Usma and it equals to 107 days (104 days
during the period 1945–2002), and the longest period refers
to Burtnieks and equals to 128 days and to Râzna where it
equals to 133 days, i.e. 21 and 26 days longer, accordingly.
During last 14 winter seasons (1988/89–2001/02), in com-
parison to the preceding study period (1926/27–1987/88),
the number of days with ice cover had decreased on average
by 14–33 days. It has decreased most for Lake Usma and
least for lakes Burtnieks and Râzna. Statistically significant
long-term changes at the P ≤ 0.05 were identified only for
Lake Râzna. Seasons with the longest and the shortest dura-
tion of ice cover are summarised in Table 4.
In order to establish the character of winter from the point
of view of severity the severity index was calculated. As it
can be seen in Figure 9, the severity index varies among the
lakes: it is higher for the lakes located in the North and East
of Latvia, which are Burtnieks and Râzna, and it is lower
for Lake Usma located in the western part. Based upon the
calculated severity index the most severe and warmest win-
ter seasons correspond to the seasons with the longest and
the shortest duration of ice cover. The most severe winters
could be observed from 1954/55 to 1958/59, 1965/66,
1968/69 and 1995/96 seasons, and the warmest winters
were in 1960/61, 1974/75, 1988/89, 2001/01 seasons. The
statistically reliable negative trend at a significance level of
P ≤ 0.05 was found only for Lake Râzna.
Changes in ice thickness. The changes in the ice thickness
of the studied lakes can be described as pseudo-cycles,
where periods with thicker and thinner ice cover alternate
T a b l e 3
EXTREME YEARS WITH THE EARLIEST AND THE LATEST DATE















































































































































































































































































































































































































































































































































































































Fig. 8. Long-term numbers of days with ice cover of the lakes Usma (A),
Burtnieks (B) and Râzna (C). The uninterrupted line is the long-term mean
value of the number of days with ice cover of the whole study period; the
interrupted lines are the long-term mean values of the number of days with
ice cover of the studied periods 1926/27–1987/88 (A), 1946/47–1987/88
(B), 1948/49–1987/88 and 1988/89–2001/02 (A, B, C).
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(Fig. 10). Ice thickness was pronouncedly higher during the
period 1945–1973 when the maximum ice thickness levels
were observed: in Lake Usma 81 cm in the season of
1946/47, in Lake Burtnieks 69 cm in the season of 1962/63,
in Lake Râzna 79 cm in the season of 1955/56. The period
of 1988–2002 is characterised by lower ice thickness, this
was the period when the warming of the climate was ob-
served and during this period also lower maximum ice
thickness levels were observed: in Usma 12 cm and in
Râzna 25 cm in the season of 1989/90, in Burtnieks 18–19
cm in the seasons of 1989/90, 1991/92 and 1992/93. How-
ever, a statistically negative trend was identified only for
the annual maximum ice thickness.
It is natural that in the Latvian lakes the mean and maxi-
mum ice thickness increase in the direction from west to
east, it is 24–31 cm and 54–56 cm, accordingly (Figs. 11
and 12). The highest mean and maximum ice thickness can
be observed in March, but they can occur also in February
and April. This depends on the heat exchange balance of the
particular year and the climatic conditions of the year that
determine the changes in the thermal and ice regimes of the
lake.
Regarding observation of the mean ice thickness of lakes no
statistically significant long-term changes were identified at
the significance level of P ≤ 0.05. In turn, concerning the
maximum ice thickness data reliable negative trends were
identified in November, January and February for Lake
Burtnieks and March for Lake Usma and a positive trend



















































































































































































































Fig. 11. Long-term monthly mean ice thickness.
T a b l e 4


















1965/66 151 1956/57 163 1965/66 163
1955/56 145 1954/55 162 1954/55 161
1931/32 141 1968/69 158 1953/54 159
1963/64,
1999/00
140 1984/85 156 1955/56 158
The shortest duration of ice cover
1990/91 23 1994/95 62 1960/61 73
1992/93 34 1960/61 71 1989/90 89
1974/75 40 1989/90 81 1982/83 95
1960/61 47 1974/75 84 1991/92 99
1929/30 49 1988/89 89 1974/75,
1996/97
100
Fig. 9. Long-term severity indexes of the lakes Usma, Burtnieks and
Râzna.
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DISCUSSION
The long-term hydrological changes of the Latvian lakes
have been determined by the set of the natural, mainly cli-
matic, and human activities factors. The adjustment works
have been performed in all the three studied lakes, and they
have served as an essential determinant of the long-term
changes in the water level. Changes in the climatic condi-
tions, in turn, have more defined the changes in the water
temperature and the ice regime, as well as the changes in
the water regime. From year 1929 to 1930, the water bed of
the Salaca River was deepened along a section of 7 km from
its mouth. In this relation the level of Lake Burtnieks was
lowered by 1 m (Glazaèeva, 1975). Regarding the study pe-
riod from 1947 to 2002 there are no data about the water
level adjustment works performed by a human at Lake
Burtnieks. Therefore, these could be considered natural pro-
cesses which have taken place mainly under the impact of
the climate change and due to the lake itself naturally trying
to restore the water level to the initial level (Fig. 2).
The long-term variation of the hydrological regime of the
lake (water level, temperature and ice conditions) is
strongly related to climatic variables. The air temperature is
the dominant variable determining the hydrological pro-
cesses and is also correlated to some extent with other rele-
vant meteorological driving variables such as solar radia-
tion, relative humidity and snowfall (Livingstone et al.,
2010). For example, statistically, air temperature is often
able to explain 60–70% of the variance in the timing of the
break-up (ice-off) on lakes (Livingstone, 1997). In Latvia
the latest study by Lizuma et al. (2007) has found that the
annual mean air temperature has increased by 1.4 oC during
last 50 years. In the study period from 1950 to 2003, the
highest increase in the mean air temperature was recorded
in spring (March, April and May) and early winter (Novem-
ber and December). Also the mean annual maximum tem-
perature increased more rapidly in April and May, while the
minimum temperature increased more rapidly in winter. In
lakes the annual and long-term water temperature changes
resemble the changes in the air temperature (Glazaèeva,
1975), which is proven also by the results of our study. Dur-
ing the ice-free period from 1988 to 2002 the water temper-
ature had experienced a long-term increase by up to 1 oC.
Statistically reliable positive trends of the water temperature
were found during the spring month, which indicate a faster
removal of the ice coverage and faster warming up of the
water.
Livigstone et al. (2009) pointed out that on interannual to
interdecadal time-scales, the timing of ice-out, the tempera-
ture of rivers and lake surfaces and the discharges rates of
streams are all directly influenced by regional climatic forc-
ing. They consequently exhibit a high degree of coherence
that is linked to the regional-scale special homogeneity of
the relevant meteorological driving variables. The air tem-
perature, which exhibits the highest degree of special homo-
geneity, is responsible for much, but not all, of the observed
coherence. It was found by Livingstone and Dokulil (2001)
in spring and summer; the coherence in lake surface water
temperature was found to be reinforced by a regional coher-
ence in meteorological driving forces other than air
temperature (e.g., wind speed in spring and high-altitude
cloud cover in summer). We can conclude that also we have
found some regional differences in the surface water tem-
perature among the studied lakes Usma, Burtnieks and
Râzna. Comparatively higher long-term average tempera-
ture was characteristic for Usma (10.3 oC) followed by
Burtnieks with 9.6 oC and Râzna with 9.1 oC.
Another factor which is referred to by many studies is the
North Atlantic Oscillation (NAO) (e.g. George, 2000;
Livingstone and Dokulil, 2001; Weyhenmeyer 2004;
Kïaviòs et al., 2009). Since air temperatures in the larger
part of Europe in winter and spring are strongly influenced
by the climate prevailing over the North Atlantic, it is not
surprising that physical lake surface and rivers variables at
these times of year are strongly linked to the NAO. As the
NAO affects a number of meteorological driving variables,
its influence on lakes is typically greater than that of any
single variables (Livingstone et al., 2009).
The global warming during last decades has had an essential
impact in determining the changes in the water regime of
the lakes of Latvia: later freezing and earlier break-off dates
can be seen, thus the number of days with ice coverage and
the average and maximum thickness of ice have decreased.
The climatic factors are the most important ones which de-
termine the regional differences between the thermal and
ice regimes which are, in turn, determined by the length of
the period between the change in the average daily tempera-
ture below 0 oC and cooling of water to zero degrees in
lakes; this depending on the size and depth of the lake, its
geographic location, water exchange there, etc. (Glazaèeva,
1975). Thus, small differences between the changes in the
thermal and ice regime of the lakes appeared in the study,
where by comparing Lake Usma of the west part of Latvia
to the lakes of the east part of Latvia (Burtnieks and Râzna)
a slightly higher long-term average water temperature could
be seen, and also the ice-coverage period and thickness of
ice were lower at the place where winters are warmer and
milder.
The results of our study on the long-term changes in the ice
regime of lakes Usma, Burtnieks and Râzna are similar to
those in the Northern countries (Korhonen (2006) in Fin-
land and Weyhenmeyer et al. (2004). The results of the
analysis clearly showed that there is a statistically signifi-
cant change towards earlier ice break-up in Finland from the
late 19th century to the present time. There is also a signifi-
cant trend towards later freezing in the longer series, and
thus also towards a shorter ice cover duration. The series of
maximum thickness of ice showed both decreasing trends in
the southern part of the country and increasing trends in the
central and northern regions. These trends were statistically
significant for approximately 50% of the observation sites.
At the same time Weyhenmeyer et al. (2004) pointed out
that the timing of ice beak-up responds much more strongly
to the interannual variations in the air temperature in south-
ern Sweden, where winters are relatively mild and duration
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